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Aminoglycoside-3′-Phosphotransferase IIIa is a widespread, promiscuous member 
of the phosphotransferase family of aminoglycoside modifying enzymes. This study 
provides results of combined calorimetry/NMR experiments to characterize and dissect 
the global thermodynamic properties of aminoglycoside–APH(3′)-IIIa complexes. 
Aminoglycoside binding to APH(3′)-IIIa is enthalpically driven with strong entropic 
penalty. 2′- and 6′-amino groups have significant contributions to the observed binding 
parameters. Formation of APH(3′)-IIIa complexes with substrate aminoglycosides shows 
a complex dependence on pH and is linked to protonation and deprotonation of both 
ligand and enzyme groups. We report pKa upshifts of ~1 unit for N2′ and N2′′′ groups of 
enzyme-bound neomycin B while the pKa of N6′ changes by 0.3 unit and N6′′′ 
experiences  no shift. Isotopic solvent and heat capacity change studies strongly suggest 
differential effects and reorganization of solvent in kanamycin and neomycin class 
complexes of the enzyme. We also determined unusually high binding ΔCp values in the 
range of -0.7 to -3.8 kcal/mol·deg which were not explained by changes in the solvent 
accessible surface area. A break at 30°C was observed in the ΔCp plot and temperature-
dependent backbone amide proton chemical shifts of four residues surrounding the 
binding site of kanamycin-APH(3′)-IIIa complex. These results may indicate specific 
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Aminoglycosides are highly potent, broad spectrum antibiotics. They can be used 
in synergy with other antibiotics and have predictable pharmacokinetics (1-3). The first 
aminoglycoside, streptomycin, was discovered in 1943 and has been very effective 
against highly serious infectious diseases of the time such as tuberculosis and the plague 
(4). Since then, various natural and synthetic aminoglycosides have been discovered or 
synthesized. Although clinical application of aminoglycosides is limited due to their side 
effects (renal and auditory toxicity) (5) and microbial resistance associated with 
widespread and misuse through decades, they are still in use, especially against 
nosocomial infections such as staphylococci and enterococci.   
The cellular target for aminoglycosides is the 16S rRNA section of the 30S 
ribosomal subunit (3, 6, 7). When they bind to their RNA target, aminoglycosides 
interfere with translational fidelity (misreading and inhibition of translocation) and cause 
premature termination of protein biosynthesis. Loss of function in membrane associated 
proteins increases cellular intake of aminoglycosides and eventually causes cell death.   
Aminoglycosides are structurally diverse hydrophilic sugar molecules carrying 
several amino and hydroxyl functional groups. At physiological pH, amino groups are 
partially protonated and make these molecules polycationic in nature. Aminoglycosides 
are carbohydrate molecules composed of two or more amino sugars linked by glycosidic 
bonds to an aminocyclitol ring, typically a 2-deoxystreptamine (2-DOS). 2-DOS 
aminoglycosides are classified as 4,5-disubstituted (neomycin) and  4,6-disubstituted 








Figure 1. Structures of aminoglycosides containing a (A) 4,6-disubstituted or (B) 4,5-
disubsituted 2-DOS ring. Single functional group differences between structurally similar 
aminoglycosides are indicated with dotted circles marking the 2′- and 6′-positions in (A) 
and (B), respectively. Dotted squares in (A) show the 3′-position. Rings A, B, C, D, and 
E are also named as primed (′), unprimed, double primed (′′), triple primed (′′′), and 
quadruple primed (′′′′) respectively. The numbering of carbon atom positions is shown on 





Aminoglycoside Modifying Enzymes 
Bacterial cells use various defensive measures against aminoglycosides such as 
efflux pumps, decreased intake and ribosomal structure modification (8). However, the 
most common bacterial resistance mechanism is enzymatic modification by 
Aminoglycoside Modifying Enzymes (AMEs) (7, 9). Aminoglycoside molecules 
covalently modified by these enzymes rendered ineffective due to poor cellular uptake 
and ribosome binding.  
There are more than 50 AME genes have been identified in plasmids, transposons 
and chromosomes of bacteria (9). There may be several genetic variants of the same 
enzyme. For example, AAC(6′)-I enzyme has 26 variants (10). On the basis of 
modification reaction, the enzymes encoded by these genes are collected under three 
groups; aminoglycoside nucleotidyltransferases (ANTs), phosphotransferases (APHs) 
and acetyltransferases (AACs). Sequence similarity is low between AME families.  
AMEs are promiscuous with respect to the aminoglycoside substrates, and the 
same enzyme can modify several structurally different aminoglycoside antibiotics. 
Furthermore, any given antibiotic can be modified by many different enzymes at the 
same or different site(s) on the antibiotic. Figure 2 shows three AMEs studied in our 
laboratory and their target modification sites on a common substrate; kanamycin A.  
Largest group of the AMEs is the acetyltransferase family. These enzymes carry 
out acetyl-coenzyme A dependent N-acetylation of the target amino groups of substrate 
aminoglycosides. There are four sub-classes which can modify aminoglycosides at 1-, 3-, 




Figure 2. Aminoglycoside modifying enzymes studied in our laboratory. Target 
modification sites for each enzyme is labeled red and indicated with an arrow.  
 
GCN5-related N-Acetyltransferases (GNAT) superfamily which also includes yeast and 
human histone acetyltransferases. ANT family, the smallest of the three groups with less 
than ten members, is typically related to resistance by Gram-negative bacteria (11).  ATP 
is the donor group in adenylation reaction. The most frequent targets for modification are 
hydroxyl groups at 4′ and 2′′.  The aminoglycoside phosphotransferase family (APHs) is 
the second largest group of aminoglycoside modifying enzymes, which contains eight 
main types; APH(3′)-I through APH(3′)-VIII (9). APH(3′)-IIIa is the most widespread 
resistance associated member of this group. It is commonly expressed in Enterococci, 
Streptococci and Staphylococci strains. Like ANTs, APH enzymes also use ATP as the 
coenzyme. Extensive sequence identity (20-40%) is shared between the family members.  
3D structure of several AMEs from three families have been resolved in recent 
years. Comparison to functionally related eukaryotic protein structures reveals 
remarkable similarities. For example, there is a high degree of structural similarity 
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between APH(3′) sub family and prokaryotic and eukaryotic protein kinases. Typical 
two-domain structure of kinases is also observed in APH enzymes. N-terminal and C-
terminal domains of known APH(3′) structures and cAMP kinase superimpose with very 
small RMS values although they don’t share a sequence similarity. Some eukaryotic 
protein kinase (EPK) inhibitors can inhibit APH(3')-IIIa and AAC(6')-APH(2"). 
Additional studies following this observation indicates that APH(3')-IIIa and AAC(6')-
APH(2") can phosphorylate some EPK peptide substrates at serine residues (12).   
 
Aminoglycoside Phosphotransferase(3′)-IIIa 
APH(3′)-IIIa (NCBI protein databank: P00554, Expasy: P00554) is the most 
promiscuous member of APH 3′-subfamily (13). APH(3′)-IIIa gene has been cloned from 
pJH1 R-plasmid isolated from an Enterococcus faecalis clinical isolate. It shows 
significant homology to other members of APH(3′) subfamily (9, 14). Protein sequence is 
composed of 264 amino acids with a molecular weight of 31 kDa. Under non-reducing 
conditions, APH(3′)-IIIa forms dimer through two sulfide bridges between residues 
Cys19 and Cys156.  
APH(3′)-IIIa can phosphorylate at least ten different aminoglycoside antibiotics. 
The modification reaction is ATP-dependent O-phosphorylation of 3′ and/or 5′′ (in the 
case of neomycin class) hydroxyl group. Mg++ is an essential ion required for activity 
through the coordination of ATP in the active site. Specificity constants (kcat/Km) is 
typically on the order of 105 M-1s-1. Steady state kinetics studies indicate a special case of 
ordered Bi-Bi kinetic mechanism for APH(3′)-IIIa called Theorell–Chance in which ATP 
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binds first with rapid equilibrium followed by aminoglycoside binding, release of 
phosphorylated aminoglycoside and rate-limiting step of ADP release (15-19) (Figure 3). 
A dissociative catalytic mechanism (Figure 4) was proposed for the phosphoryl 
transfer reaction catalyzed by the enzyme where nucleophilic attack of 3′-hydroxyl 
oxygen of the aminoglycoside on the γ-phosphate of ATP takes place after the bond 
between leaving phosphate group and β-phosphate is broken. According to the proposed 
model, a metaphosphate-like transition state which is stabilized by Mg+2 ion and Asp208 
forms. Residues Met26 and Ser27 also play critical roles in catalysis by interacting with 
β- and γ-phosphate groups of ATP respectively. Initial aminoglycoside deprotonation was 
found to be not essential for the phosphate transfer (20).   
 
 





Figure 4. The catalytic mechanism of APH(3′)-IIIa. 3′-OH position of the substrate 
aminoglycoside is labeled red. The metaphosphate-like transition state is indicated in the 
middle.  
 
by aminoglycoside (Ag) binding. Following group transfer, phosphorylated aminoglycoside 
(Ag-Phosphate) is released. ADP dissociation is the last and rate-limiting step. 
Several APH(3′)-IIIa crystal structures have become available in recent years. 
Structure of the holo-enzyme (ADP and AMP-PNP bound) was provided by Hon et. al. 
(21) followed by the release of the apo-form structure by Berk et. al. (22). The first 
aminoglycoside substrate bound structures (kanamycin A and neomycin B) of APH(3′)-
IIIa were resolved by Fong et. al. in 2002 (Figure 5) (13). Our laboratory studied enzyme 
bound conformations of amikacin and butirosin A using APH(3′)-IIIa (23-25).  
Part I of this thesis presents the first published work on general thermodynamic 
characterization of aminoglycoside-APH(3′)-IIIa interactions. In Part II, we report, again 
for the first time, pKa values of an enzyme bound aminoglycoside and use this 
information to dissect the calorimetrically-derived global proton-linkage data. The 
following chapter focuses on solvent effects and heat capacity change of aminoglycoside-








Figure 5. Structure of the ternary neomycin B-ADP-APH(3′)-IIIa complex. Mg++ ions are 
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PART II: THERMODYNAMICS OF AMINOGLYCOSIDE BINDING 
TO AMINOGLYCOSIDE-3′-PHOSPHOTRANSFERASE IIIA 










This section is a slightly revised version of a manuscript by Can Özen and Engin H. 
Serpersu published in Biochemistry in 2004: 
 
Özen, C., and Serpersu, E. H. (2004) Thermodynamics of aminoglycoside binding to 
aminoglycoside-3′-phosphotransferase IIIa studied by isothermal titration calorimetry, 
Biochemistry. 43, 14667–14675. 
 
Abstract 
 The aminoglycoside-3′-phosphotransferase IIIa [APH(3′)-IIIa] phosphorylates 
aminoglycoside antibiotics and renders them ineffective against bacteria. APH(3′)-IIIa is 
the most promiscuous aminoglycoside phosphotransferase enzyme, and it modifies more 
than 10 different aminoglycoside antibiotics. A wealth of information exists about the 
enzyme; however, thermodynamic properties of enzyme–aminoglycoside complexes are 
still not known. This study describes the determination of the thermodynamic parameters 
of the binary enzyme–aminoglycoside and the ternary enzyme–metal-ATP–
aminoglycoside complexes of structurally related aminoglycosides using isothermal 
titration calorimetry. Formation of the binary enzyme–aminoglycoside complexes is 
enthalpically driven and exhibits a strongly disfavored entropic contribution. Formation 
of the ternary enzyme–metal-ATP–aminoglycoside complexes yields much smaller 
negative ∆H values and more favorable entropic contributions. The presence of metal-
ATP generally increases the affinity of aminoglycosides to the enzyme. This is consistent 
with the kinetic mechanism of the enzyme in which ordered binding of substrates occurs. 
However, the observed ∆H values correlate with neither kinetic parameters kcat, Km, and 
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kcat/Km nor with the molecular size of the substrates. Comparison of the thermodynamic 
properties of the complexes formed by structurally similar aminoglycosides indicated that 
the 2′- and the 6′-amino groups of the substrates are involved in binding to the enzyme. 
Thermodynamic properties of the complexes formed by aminoglycosides differing only 
at the 3′-hydroxyl group suggested that the absence of this group does not alter the 
thermodynamic parameters of the ternary APH(3′)-IIIa–metal-ATP–aminoglycoside 
complex. Our results also indicate that protonation of ligand and protein ionizable groups 
is coupled to the complex formation between aminoglycosides and APH(3′)-IIIa. 
Comparison of ∆H values for different aminoglycoside–enzyme complexes indicates that 















Materials and Methods 
Aminoglycoside antibiotics, adenosine 5′-triphosphate (ATP), and all other 
chemicals were of highest available purity and were obtained from Sigma (St. Louis, 
MO). The strong anion-exchange medium POROS 20HQ was purchased from Applied 
Biosystems (Foster City, CA). 
Protein Purification. APH(3′)-IIIa was expressed in Escherichia coli BL21(DE3) 
carrying the overexpression plasmid pETPCR6, which was provided by Dr. Gerard D. 
Wright. APH(3′)-IIIa was purified using a modified version of the original procedure 
described by McKay et al. (1). Ten liters of Luria broth (LB) media in a New Brunswick 
(Edison, NJ) BioFlo 110 fermentor vessel was inoculated with a 100 mL overnight grown 
subculture. The cells were grown at 37 °C. The culture was induced at the mid log phase 
(OD600 = 0.6) with 1 mM final concentration of IPTG. After a 5 h induction period, the 
culture was divided into 1.5 L fractions, and then the cells were harvested by 
centrifugation. Each fraction was solubilized in 35 mL of lysis buffer (50 mM Tris, 5 mM 
EDTA, 200 mM NaCl, 1 mM PMSF, 0.2 mM DTT) and lysed by three to four passages 
through a French press at 16000 psi. Cell debris was removed by centrifugation, and the 
supernatant was diluted to 50 mL with buffer A (50 mM Tris, 1 mM EDTA, pH 8.0) 
before loading it onto a strong anion-exchange POROS 20HQ column (250 x 4.6 mm) 
attached to a BIOCAD 700E perfusion chromatography workstation from Applied 
Biosystems. After the cell hydrolysate was loaded, the column was washed with four 
column volumes of buffer A. A linear gradient of 0-20% buffer B in buffer A was applied 
through five column volumes to elute contaminant proteins. The pure APH(3′)-IIIa was 
then eluted with two column volumes of 20% buffer B in buffer A. Pooled fractions were 
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dialyzed against buffer A, freeze-dried, and stored at –80 °C. The purity of the enzyme 
was >98% as judged by SDS–PAGE. The activity of the enzyme was determined by 
using a coupled-enzyme assay as described previously (1). 
ITC Experiments. Isothermal titration calorimetry experiments were performed at 
37 °C using a VP-ITC microcalorimeter from Microcal, Inc. (Northampton, MA). 
Measurements were carried out in 50 mM Tris or Bicine buffers which also contained 
100 mM KCl at pH values of 7.5 and 8.5. Enzyme preparations were dialyzed extensively 
against buffer, and ligand solutions were prepared in the final dialyzate. Both solutions 
were degassed under vacuum for 10 min. Titrations consisted of 29 injections 
programmed as 10 μL per injection and separated by 240 s. Cell stirring speed was 300 
rpm.  
Binary complex titrations were performed by titrating 0.75–3.0 mM 
aminoglycoside solution into a solution containing 50-100 μM APH(3′)-IIIa in the sample 
cell. To obtain reliable dissociation constants, the c-value, a parameter obtained by the 
multiplication of the association constant and the total concentration of ligand binding 
sites (2), was kept between 10 and 100 for all titrations. Due to tight binding of neomycin 
B and paromomycin I (c-values were ~600 at 80 μM enzyme concentration), the ternary 
titrations with these antibiotics were repeated at 10 μM enzyme concentration for more 
accurate determination of the dissociation constants. CaCl2 (1.5 mM) and ATP (1.0 mM) 
were present in the syringe and sample cell during ternary complex titrations. Control 
runs were performed by titrating ligands to buffer, and the resulting reference signal was 
subtracted from corresponding experimental data. The enzymatic activity of APH(3′)-IIIa 
was tested before and after titrations, and no loss of activity was detected. 
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Thermodynamic parameters N (stoichiometry), KA (association constant), and ∆H 
(enthalpy change) were obtained by nonlinear least-squares fitting of experimental data 
using a single-site binding model of the Origin software package (version 5.0) provided 
with the instrument. The free energy of binding (∆G) and entropy change (∆S) were 
obtained using the equations: 
∆G = –RT ln KA      (1) 
∆G = ∆H – T∆S      (2) 
The affinity of the aminoglycoside to the enzyme and enzyme–CaATP complex is given 
as the dissociation constant (KD = 1/KA). CaATP, a competitive inhibitor of the enzyme 















Results and Discussion 
ITC is a direct method for characterizing the stoichiometry, affinity, and enthalpy 
of binding reactions in solution (4–6) and has been employed in binding studies of 
saccharides with their partner lectins (7–9) or proteins (10), or aminoglycoside–RNA 
complexes (11), aminoglycoside–acetyltransferase interactions (12), and nucleotide 
binding to APH(3′)-IIIa (13). In this study, we used ITC to determine the thermodynamic 
parameters for aminoglycoside binding to APH(3′)-IIIa in the presence and absence of 
CaATP. Several aminoglycosides with 4,5- and 4,6-disubstituted 2-deoxystreptamine 
rings were used in binding studies (Part I Figure 1). 
In general, the binding of aminoglycosides to APH(3′)-IIIa is an enthalpically 
driven process accompanied by an unfavorable entropic contribution. Negative ∆H values 
associated with the formation of binary APH(3′)-IIIa–aminoglycoside and ternary 
APH(3′)-IIIa–CaATP–aminoglycoside complexes suggest that favorable binding contacts 
such as polar, electrostatic, van der Waals, and hydrogen bonds exist between 
aminoglycosides and APH(3′)-IIIa. Exothermic heat and binding affinities were not, 
however, proportional with the size of aminoglycosides (i.e., larger aminoglycosides did 
not necessarily exhibit greater heats of association or tighter binding). Also, there was no 
correlation between the heat of binding and the kinetic parameters Km, kcat, or kcat/Km. 
Binary Enzyme–Aminoglycoside Complexes. Calorimetric titration results show 
that formation of APH(3′)-IIIa–aminoglycoside complexes exhibits large, exothermic 
heats of association, and they are entropically disfavored (Table 1). This observation 
indicates that the sum of the total binding entropy due to solvation effects and to the 




Table 1. Thermodynamic Parameters for Aminoglycoside Binding to APH(3′)-IIIa 













TRIS 6.2 –33.0 25.6 –7.4 
Kanamycin A 
Bicine 4.6 –38.3 
–44.9 
30.8 –7.5 
TRIS 0.3 –22.4 13.2 –9.2 
Kanamycin B 
Bicine 0.5 –30.8 
–41.3 
21.8 –9.0 
TRIS 0.8 –29.2 20.5 –8.7 
Tobramycin 
Bicine 0.6 –37.1 
–47.0 
28.3 –8.8 
TRIS 92.6 –19.5 13.8 –5.7 
Amikacin 
Bicine 43.5 –18.8 
–17.9 
12.6 –6.2 
TRIS 1.7 –30.1 22.0 –8.1 
Ribostamycin 
Bicine 1.9 –28.1 
–25.6 
20.0 –8.1 
TRIS 0.26 –33.4 24.1 –9.3 
Neomycin B 
Bicine 0.30 –43.3 
–55.7 
34.0 –9.3 
TRIS 0.44 –30.4 21.4 –9.0 
Paromomycin I 
Bicine 0.30 –36.4 
–43.9 
27.1 –9.3 
TRIS 0.81 –33.6 25.0 –8.6 
Lividomycin A 
Bicine 0.57 –44.1 
–57.3 
35.3 –8.8 
a Determined at 310 K. KD values were calculated from ITC-derived KA. Fitting Errors: 
KD, 2–12%; ΔH, 0.2–3%. The stoichiometry of complex formation was 1.0 ± 0.2 in all 
titrations. b Intrinsic enthalpy changes (ΔHint) were calculated using eqs 3a and 3b. 
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APH(3′)- IIIa was greatly reduced as a result of complex formation. However, the large 
exothermic heats of association compensate for the entropic penalty to yield negative ∆G 
values in each case. In all cases, the best fits were obtained with a single-site model. 
Figure 1 shows the titration isotherms obtained for binary titrations of APH(3′)-IIIa with 
the tightest (neomycin B) and the weakest (amikacin) binding aminoglycosides. The 
differences between the heats of association and the binding affinities of the two 
aminoglycosides are clearly visible in this figure. 
There were no clear trends with respect to dissociation constant (KD) or other 
thermodynamic parameters to distinguish aminoglycosides with the 4,5- or 4,6-
disubstituted 2-DOS rings from each other. While KD values varied ~400-fold, ∆Hobs 
values were between –18.8 and –44.1 kcal/mol, and T∆S values were between –12.6 and 
–35.3 kcal/mol. Overall, however, all binary enzyme–aminoglycoside complexes gave 
negative ∆G values. Also, with the exception of amikacin, all ∆G values were within 1.8 
kcal/mol. The results observed with amikacin are somewhat expected since amikacin is 
one of the worst substrates of APH(3′)-IIIa (high Km, low kcat, and kcat/Km), with the 
lowest affinity and the smallest negative ∆G among the aminoglycosides tested. 
Amikacin has a bulky group attached to the N-1 of the 2-DOS ring (Part I Figure 1), 
which may interfere with the interaction of aminoglycoside with the enzyme. This may 
explain why amikacin is still a clinically useful antibiotic. 
Observed ∆H values were different for the same complex when titrations were 
performed in buffers with different heats of ionization [Tris, 11.7 kcal/mol (14), vs 
Bicine, 6.5 kcal/mol (15)]. This observation indicates that the formation of enzyme–




































































Figure 1. Isotherms of (A) 3.0 mM amikacin and (B) 1.5 mM neomycin B titration to 80 
μM APH(3′)-IIIa. All solutions contained 50 mM Tris, pH 7.5, and 100 mM KCl, and 
titrations were performed at 310 K. The upper panel shows the raw data (thermal power). 
Time integration of the thermal power yields the heat of injection, which is plotted 
against the molar ratio of ligand to enzyme in the lower panel. The solid line in bottom 






protonation/deprotonation occurs in the complex. The data obtained in two different 
buffers can then be used to determine the intrinsic enthalpy changes (∆Hint) and net 
number of binding-coupled protons (∆n) for aminoglycoside–APH binary complex 
formation. These values were calculated by simultaneous solution of the equations (16): 
∆Hobs1 = ∆Hint + ∆Hion1∆n     (3a) 
∆Hobs2 = ∆Hint + ∆Hion2∆n     (3b) 
where ∆Hobs is the observed enthalpy change, ∆Hion is the ionization enthalpy change for 
the particular buffer used, and ∆n is the net number of protons released or absorbed by 
the buffer upon complex formation. Positive values of the determined ∆n for the 
formation of the binary enzyme–aminoglycoside complexes with kanamycin A, 
kanamycin B, tobramycin, neomycin B, paramomycin, and lividomycin A indicate 
binding-coupled protonation whereas negative values observed for ribostamycin and 
amikacin are due to the deprotonation of ligand and/or protein groups.  
The data shown in Table 1 also indicates that ∆Hint values show a large variation 
for different aminoglycosides (more than ~3-fold). In addition, as shown in Table 2, the 
observed ∆n values for the binary enzyme–aminoglycoside complexes with neomycin B 
and lividomycin A exceed the total fraction of –NH2 groups on these ligands. Thus, 
additional protonation must occur in the enzyme side chains. Also, comparison of ∆n 
values of kanamycin A and kanamycin B shows that the difference (∆∆n) is 0.6. The only 
difference between these two antibiotics is the presence of an amino (kanamycin B) vs 
hydroxyl (kanamycin A) at the 2′-position. However, the protonation of this group alone 
cannot be responsible for the observed ∆n with kanamycin B, because it is already 92% 
protonated at pH 7.5. Similarly, the comparison of the complexes of neomycin B and 
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ribostamycin shows a ∆∆n value of 2.28, which exceeds the differences in the fraction of 
–NH2 groups of the two antibiotics. These observations suggest that not only does the 
ionization of enzyme side chains contribute to the observed heat of the complex 
formation, but the contribution is different for each aminoglycoside. These are in 
excellent agreement with the results obtained by NMR studies. Heteronuclear 1H–15N 
HSQC spectra acquired with enzyme–aminoglycoside complexes using 15N-enriched 
enzyme showed that different sets of backbone amide resonances were shifted with each 
aminoglycoside, suggesting that the conformation of the active site is altered to 
accommodate each aminoglycoside (Whittemore and Serpersu, unpublished data). Thus, 
the contribution of the enzyme to the determined ∆Hint may be different for each 
aminoglycoside. 
Ternary Enzyme–CaATP–Aminoglycoside Complexes. An exothermic heat also 
accompanied titration of aminoglycosides into the enzyme–CaATP complex. However, 
the observed heat was significantly lower than the ∆H values observed in the binary 
titrations. As shown in Figure 2, the titration of ribostamycin into the solutions containing 
enzyme alone or the enzyme–CaATP complex exhibits different patterns. Comparison of 
aminoglycoside binding to APH(3′)-IIIa shows that binding is generally tighter or 
unchanged in the presence of CaATP (Tables 1 and 3).These results are in agreement 
with previous steady-state kinetics, viscosity, thio, and solvent isotope effect studies (19, 
20) suggesting a special case of ordered Bi-Bi kinetic model for APH(3′)-IIIa called 
Theorell–Chance mechanism in which ATP binds first with rapid equilibrium followed 
by aminoglycoside binding, release of phosphorylated aminoglycoside and lastly release 




Table 2. Protonation Coupled to Aminoglycoside Binding to APH(3′)-IIIa (Binary 
Complex) at pH 7.5 
  Total Fraction of NH2a Δnb 
Kanamycin A 2.51 1.02 
Kanamycin B 2.59 1.62 
Tobramycin 2.59 1.52 
Amikacin 1.25 –0.13 
Ribostamycin 1.71 –0.38 
Neomycin B 1.15 1.90 
Paromomycin I 1.18 1.15 
Lividomycin A 1.14 2.03 
a The total fraction of deprotonated amino groups was calculated on the basis of the 
determined  pKa values of aminoglycosides (11, 17, 18). b The net number of binding-













































































Figure 2. ITC profiles of 1.2 mM ribostamycin titration to 80 μM APH(3′)-IIIa in the 
absence (A) and presence (B) of CaATP. Other experimental conditions were as 
described in Figure 1. The raw data are shown in the upper panels, and plots of the heat 
of injection against the molar ratio of ligand to enzyme are shown in the lower panels 
with the best-fit lines to a one-site model. The steeper saturation curve in (B) yields more 







Table 3. Thermodynamic Parameters for Aminoglycoside Binding to APH(3′)-













TRIS 0.99 –9.4 0.9 –8.5 
Kanamycin A 




TRIS 0.22 –8.2 –1.2 –9.4 
Kanamycin B 




TRIS 0.22 –9.1 –0.3 –9.4 
Tobramycin 




TRIS 33.3 –4.8 –1.5 –6.3 
Amikacin 




TRIS 0.27 –11.6 2.3 –9.3 
Ribostamycin 




TRIS 0.13 –12.2 2.4 –9.8 
Neomycin B 




TRIS 0.16 –11.5 1.8 –9.7 
Paromomycin I 




TRIS 0.78 –10.5 1.8 –8.7 
Lividomycin A 




a Determined at 310 K. KD values were calculated from ITC-derived KA. Fitting Errors: 
KD, 2–12%; ΔH, 0.2–3%. The stoichiometry of complex formation was 1.0 ± 0.2 in all 
titrations. b Intrinsic enthalpy changes (ΔHint) and  net number of binding-coupled 




observed in the formation of the binary enzyme–aminoglycoside complexes were mostly 
due to conformational changes in enzyme or ligand or both. Our earlier work showed that 
the enzyme-bound aminoglycosides, unlike their unbound forms, do not necessarily adopt 
the lowest energy conformation (21, 22).Thus, enzyme binding causes conformational 
changes in aminoglycosides. In addition, NMR spectra acquired with enzyme, enzyme–
CaATP,enzyme–aminoglycoside, and enzyme–CaATP–aminoglycoside complexes,using 
uniformly 15N-enriched APH(3′)-IIIa, showed that the binding of aminoglycosides to the 
APH(3′)-IIIa or APH(3′)-IIIa–CaATP caused a larger number of backbone resonances to 
shift when compared to the addition of CaATP to the enzyme or enzyme–aminoglycoside 
complex, suggesting that the binding of aminoglycoside causes significant 
conformational changes in the enzyme (Whittemore and Serpersu, unpublished data). 
In the ternary complex formation, as was the case with the binary complexes, 
there were no trends separating the aminoglycosides with 4,5-disubstituted 2-DOS from 
those with 4,6-disubstituted 2-DOS with respect to the thermodynamic parameters. 
Overall, the entropic contribution was more favorable in the ternary complexes with all 
aminoglycosides when compared to the respective binary complexes. An explanation for 
this observation can be that the binding in the ternary complex is accompanied by 
expulsion of more water molecules from the binding interface when compared to the 
binary aminoglycoside–enzyme interaction. Thus, gain in entropy of the freed water 
molecules would provide a more favorable driving force for the formation of the ternary 
complex. Alternatively, the more favorable entropic contribution may come from the 
increased hydrophobic interactions between the enzyme and the ligands. It is already 
shown in the crystal structure of the enzyme with substrates (23) that the adenine moiety 
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of MgADP is involved in a stacking interaction with the aromatic ring of the Tyr 42. This 
interaction is absent in the binary enzyme–aminoglycoside complex. 
The spread between the lowest and highest affinity toward the enzyme was 
somewhat narrower in ternary complexes. Overall, ∆G values for each antibiotic were 
only slightly more negative in the ternary complexes when compared to the respective 
binary complexes. In the ternary complexes, more uniform ∆n values were obtained, and 
the values of ∆Hint varied between –14.5 and –36.6 kcal/mol. The analysis of these 
values, however, is even more complicated than those of the binary complexes due to 
contributions that may result from the interactions of ATP with protein and ligand 
coordination to the metal ion. On the other hand, comparison of the dissociation constants 
of various enzyme–aminoglycoside complexes (a thermodynamic property which is not 
directly correlated to the heat of reaction) with several aminoglycosides that have a 
structural difference of either a single functional group or a complete sugar ring between 
two aminoglycosides afforded some clues about the roles of these groups in enzyme–
aminoglycoside interactions. Several specific comparisons are presented in the following 
paragraphs. 
2′-Amino vs Hydroxyl. Kanamycin A and kanamycin B differ only by the 
presence of an amino group at the 2′-position of kanamycin B instead of the hydroxyl in 
kanamycin A (Part I Figure 1). ∆Hint is 3.6 kcal/mol less negative with kanamycin B 
when compared to kanamycin A in the binary enzyme–aminoglycoside complex (Table 
1), while the affinity of kanamycin B to the enzyme is ~15-fold higher than that of 
kanamycin A. These differences between the kanamycins are significantly reduced in the 
ternary complexes (Table 3). If one assumes the ability of the protonated (or 
 
 30
unprotonated) amino group to form stronger hydrogen bonds than the hydroxyl group, 
then the expected ∆H should have been more negative with kanamycin B. On the other 
hand, increased strength of additional hydrogen bonds mediated by the 2′-amino group 
may weaken other favorable interactions, i.e., altered cooperativity among hydrogen 
bonds, causing a less enthalphically driven complex formation for kanamycin B. 
Alternatively, the more negative ∆H with kanamycin A may be the result of larger 
conformational changes in enzyme or antibiotic or both. If the protonated amino group is 
involved in ionic interactions with the protein side chains, then this would provide more 
positive entropic contribution to the binding through desolvation. The second alternative 
appears to account for the relatively more favorable entropic terms in the binary and 
ternary complexes of kanamycin B with respect to kanamycin A. 
A crystal structure for the binary kanamycin–APH(3′)-IIIa complex is not 
available; however, the crystal structure of the ternary APH(3′)-IIIa–MgADP–kanamycin 
A complex is available (23). Examination of the crystal structure reveals that the closest 
enzyme atom to the 2′-hydroxyl oxygen is the side chain carboxyl oxygen of Asp 190 at a 
distance of 4.2 Å in the ternary complex (Figure 3), and therefore the 2′-position was not 
considered among the enzyme contacts in previous structural analyses (23). The pKa of 
the 2′-amino group is ~8.6 (18), which is the highest of all amine groups on kanamycin 
B. At pH 7.5 only the 2′-amino group would be ~90% protonated while all others would 
be ~50% or less protonated. Experiments performed with the ternary complexes at pH 8.5 
(Figure 4) showed that ∆Hint for kanamycin A was only slighty changed, while it became 
significantly more negative for kanamycin B. The entropic contributions were reversed in 





Figure 3. Crystal structures of (A) kanamycin A and (B) neomycin B complexed with 
ADP and APH(3′)-IIIa (23). Images were produced by Deep View (24) and Pymol (25). 
The relevant distances between ligand functional groups and enzyme residues are 





Figure 4. Heat of injection observed in the titration of kanamycin A to 80 μM APH(3′)-
IIIa in the presence of CaATP at pH 7.5 (A) and 8.5 (B). Other experimental conditions 
were as described in Figure 1. The solid line represents the best fit to the data using a 




Table 4. Thermodynamic Parameters for Aminoglycoside Binding to APH(3′)-
IIIa–CaATP (Ternary Complex) at pH 8.5a 
  
  











       
 
TRIS 28.3 –3.7 –2.8 –6.5 
Kanamycin A 
Bicine 24.2 –17.2 
–34.1 
10.7 –6.5 2.60
TRIS 9.4 –8.5 1.3 –7.1 
Kanamycin B 
Bicine 4.4 –26.2 
–48.3 
18.6 –7.6 3.40
TRIS 12.6 –7.0 0.09 –7.0 
Tobramycin 
Bicine 5.6 –25.4 
–48.4 
18.0 –7.4 3.54
TRIS 0.40 –11.1 2.2 –8.9 
Neomycin B 
Bicine 0.17 –30.9 
–55.7 
21.3 –9.6 3.81
TRIS 3.7 –10.9 3.1 –7.8 Paromomycin 
I Bicine 1.88 –27.8 
–48.9 
19.7 –8.1 3.25
a Determined at 310 K. KD values were calculated from ITC-derived KA. Fitting Errors: 
KD, 2–10%; ΔH, 0.5–6%. The stoichiometry of complex formation was 1.0 ± 0.2 in all 
titrations. b Intrinsic enthalpy changes (ΔHint) and net number of binding-coupled 





2′-amino group of unbound kanamycin B would be ~50% protonated while the others are 
only ~10% protonated. Since kanamycin A lacks the 2′-amino group, at pH 8.5, all of its 
amino groups would be only about 10% protonated. This suggests that charged amino 
groups of aminoglycosides   provide    favorable    binding    interactions    in    enzyme–
aminoglycoside    complexes.  
These observations are also consistent with the involvement of the charged 2′-
amino group in enzyme–kanamycin B interactions. The determined ∆∆n value between 
the kanamycins is 0.8 at pH 8.5. This value, again, exceeds the total protonation capacity 
of the 2′-amino group and suggests that other groups must be involved. These results also 
suggest that even very small structural differences between ligands may alter other 
enzyme–ligand interactions involving the similar structural parts of ligands (i.e., 
increased or decreased cooperativity among the hydrogen bonds). Thus observed changes 
in the thermodynamic parameters may not easily be reconciled in a quantitative manner. 
6′-Amino vs Hydroxyl. The presence of an amino or hydroxyl group at the 6′-
position is the only difference between neomycin B (amine) and paromomycin I 
(hydroxyl) (Part I Figure 1). Binary complexes of both aminoglycosides with the enzyme 
exhibit similar KD values, but their intrinsic binding enthalpies differ by 13.4 kcal/mol 
(Table 1). However, when the ternary titrations were performed at pH 8.5, at which only 
the 6′-amino group would be ~50% protonated while the others are in a ~10% protonated 
state, significant differences were observed between the binding pattern of the two 
antibiotics. The dissociation constant of paromomycin I from the ternary APH(3′)-IIIa–
CaATP–paromomycin I complex was increased by ~20-fold, while the same effect was 
only 1.3-fold for neomycin B. This observation suggests that the remaining charge on the 
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6′-amino group of neomycin B is responsible for the ~10-fold tighter binding of this 
antibiotic to the enzyme when compared to paromomycin I at pH 8.5. Thus, the 6′-amino 
group must be involved in enzyme–aminoglycoside interactions, and it contributes 1.3 
kcal/mol favorably to ∆G when it is in the ~50% protonated state. Although the 
determined ∆∆n value of 0.56 can be attributed to the protonation of the 6′-amino group 
alone, as indicated above, this may be coincidental, and contributions due to 
protonation/deprotonation of other groups cannot be ruled out. 
The crystal structure of the ternary APH(3′)-IIIa–MgADP–neomycin B complex 
shows that the 6′-amino group is 2.6 Å away from one of the carboxyl oxygens of the C-
terminal residue Phe 264 (Figure 3). Entropic contributions are similar in the ternary 
complexes of neomycin B and paramomycin I at pH 8.5. Thus, the observed difference in 
∆G is solely due to the difference in ∆H, and it may reflect the ability of the amino group 
to form stronger hydrogen bonds than the hydroxyl group with Phe 264. 
The importance of the 2′- and the 6′-amino groups is also supported by the 
chemical modification studies in which particular amino groups were one-by-one 
deaminated to study their role in enzyme catalysis (26). Elimination of the 2′-and the 6′-
amino groups was shown to increase Km and bring about 10- and 30-fold losses of 
catalytic efficiency of APH(3′)-IIIa, respectively. In this work, we showed that even 
replacement of these amino groups by hydroxyl groups still shows significant effects on 
the thermodynamic properties of the binary and ternary enzyme–aminoglycoside 
complexes. 
3′-Deoxy vs Hydroxyl. Tobramycin, a competitive inhibitor of APH(3′)-IIIa, lacks 
the 3′-hydroxyl group of kanamycin B and therefore cannot be modified by the enzyme. 
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Comparison of KD for tobramycin and kanamycin B shows that the presence or absence 
of a hydroxyl group at the 3′-position does not have an effect on the affinity of 
aminoglycoside to the enzyme–metal-ATP complex. As was the case with kanamycin A 
vs kanamycin B, there were differences between the thermodynamic parameters of the 
binary complexes of kanamycin B and tobramycin with APH(3′)-IIIa (Table 1). 
Kanamycin B exhibited lower ∆H and T∆S values in the binary complex. These 
differences disappeared almost completely in the ternary complexes, yielding not only 
identical ∆G and KD values but also similar ∆H and T∆S values (Table 3). These 
observations suggest that once the nucleotide-binding site is occupied, the 3′-hydroxyl 
group has no significant contribution to the thermodynamic parameters. This is somewhat 
surprising since the 3′-OH is the point of modification by APH(3′)-IIIa, and it is located 
near the catalytically required residue Asp 190 (Figure 3). Thus, one would expect this 
group to be positioned precisely for a nucleophilic attack on the γ-phosphoryl group of 
ATP via interaction(s) with Asp 190. A plausible explanation may be that the removal of 
the hydroxyl group leads to stronger interactions via other existing hydrogen bonds 
between the aminoglycoside and the enzyme and/or alters the organization of water in the 
active site, which compensates for the loss of a hydrogen bond through the 3′-hydroxyl. 
These results, again, clearly suggest that interpretation of thermodynamic data, even for 
very similar compounds, may not be straightforward, and detailed structural information 
on the complexes of each compound is necessary for a more quantitative interpretation.  
Size of Substrates. Comparison of thermodynamic parameters of the binary and 
ternary complexes of ribostamycin (three rings), neomycinB/paramomycin I (four rings), 
and lividomycin A (five rings) shows that the determined ∆Hint is significantly different 
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for ribostamycin. Since ribostamycin is the smallest of them, these observations suggest 
that the fourth rings of the longer aminoglycosides contribute to binding. Examination of 
the data also yields that the fifth ring of lividomycin A does not contribute to binding. 
The crystal structure of the APH(3′)-IIIa–MgADP–neomycin B complex (23) shows that 
the side chain nitrogens and oxygens of Asn 134, Asp 193, Ser 194, and Glu 230 are 
within 4 Å distance of the fourth ring of neomycin B. Thus one or more of these side 
chains may interact with this ring. 
Enthalpy–Entropy Compensation. The determined ∆Hobs and T∆S values were 
plotted for the binary and the ternary complexes to investigate the enthalpy–entropy 
compensation of the aminoglycoside binding to APH(3′)-IIIa. Enthalpy–entropy 
compensation for the formation of the binary and ternary complexes of each 
aminoglycoside are shown in Figures 5 and 6. Plots of enthalpy–entropy compensation 
with a slope of unity indicate that changes in binding enthalpies (∆∆H) are equally 
compensated by changes in binding entropies (∆∆S) between the different ligands of an 
enzyme. If ∆∆H is greater than ∆∆S, a slope greater than unity is obtained. In the case 
where ∆∆H is smaller than the ∆∆S, the slope is smaller than unity. Such plots for binary 
and ternary complexes of APH(3′)-IIIa with substrates yielded slopes of 1.09 and 1.04, 
respectively (Figure 6), indicating that, in both cases, changes in binding enthalpies of 








Figure 5. Thermodynamic parameters of aminoglycoside binding to (A) APH(3′)-IIIa and 
(B) the APH(3′)-IIIa–CaATP complex at 310 K in Bicine buffer. Bars represent ∆H 
(black), –T∆S (white), and ∆G (crossed). Abbreviations: Kan. A, kanamycin A; Kan. B, 
kanamycin B; Tob., tobramycin; Ami., amikacin; Rib., ribostamycin; Neo. B, neomycin 




Figure 6. Enthalpy–entropy compensation plots constructed by linear regression analysis 
of binding data from Tables 1 and 3. (A) Binary enzyme–aminoglycoside complexes 
(slope = 1.09, R = 0.99) and (B) ternary enzyme–CaATP–aminoglycoside complexes 




With the exception of amikacin, the free energies of formation for the binary 
enzyme–aminoglycoside and the ternary enzyme–CaATP–aminoglycoside complexes 
were similar to each other regardless of the structure of the aminoglycosides involved. 
The heat of formation and the entropic contribution to complex formation, however, 
showed significant variation among the aminoglycosides. The formation of all binary 
complexes exhibits large negative ∆H values with strongly disfavored entropic 
contribution. This is significantly different from the aminoglycoside–RNA interactions 
that show favorable entropic contribution to the complex formation (11). The formation 
of ternary complexes, on the other hand, was entropically more favored when compared 
to the binary complexes. Overall, there were no strong correlations between the 
thermodynamic parameters and the size of the aminoglycosides, or the kinetic 
parameters, or the substitution pattern of the 2-DOS ring (4,5 vs 4,6). Also, comparisons 
between structurally very similar aminoglycosides showed that the presence of an amino 
or hydroxyl group at the 2′- and the 6′-positions affected the thermodynamic properties of 
various enzyme–aminoglycoside complexes significantly, while the lack of a hydroxyl 
group at the 3′-position had no detectable effect. Similarly, additional sugar rings of 
larger aminoglycosides beyond the fourth ring appear to have no significant effect on the 
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PART III: DISSECTION OF AMINOGLYCOSIDE–ENZYME 
INTERACTIONS: A CALORIMETRIC AND NMR STUDY OF 












This section is a slightly revised version of a manuscript by Can Özen, Joseph M. Malek, 
and Engin H. Serpersu published in JACS in 2006: 
 
Özen, C., Malek, J. M., and Serpersu, E. H. (2006) Dissection of Aminoglycoside–
Enzyme Interactions: A Calorimetric and NMR Study of Neomycin B Binding to the 
Aminoglycoside Phosphotransferase(3′)-IIIa, JACS. 128, 15248–15254. 
 
Abstract 
In this work, for the first time, we report pKa values of the amino functions in a 
target-bound aminoglycoside antibiotic, which permitted dissection of the 
thermodynamic properties of an enzyme–aminoglycoside complex. Uniformly enriched 
15N-neomycin was isolated from cultures of Streptomyces fradiae and used to study its 
binding to the aminoglycoside phosphotransferase(3′)-IIIa (APH) by 15N NMR 
spectroscopy. 15N NMR studies showed that binding of neomycin to APH causes upshifts 
of ~1 pKa unit for the amines N2′ and N2′′′ while N6′ experienced a 0.3 pKa unit shift. 
The pKa of N6′′′ remained unaltered, and resonances of N1 and N3 showed significant 
broadening upon binding to the enzyme. The binding-linked protonation and pH 
dependence of the association constant (Kb) for the enzyme–aminoglycoside complex 
was determined by isothermal titration calorimetry. The enthalpy of binding became 
more favorable (negative) with increasing pH. At high pH, binding-linked protonation 
was attributable mostly to the amino functions of neomycin; however, at neutral pH, 
functional groups of the enzyme, possibly remote from the active site, also underwent 
protonation/deprotonation upon formation of the binary enzyme–neomycin complex. The 
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Kb for the enzyme–neomycin complex showed a complicated dependence on pH, 
indicating that multiple interactions may affect the affinity of the ligand to the enzyme 
and altered conditions, such as pH, may favor one or another. This work highlights the 
importance of determining thermodynamic parameters of aminoglycoside–target 
interactions under different conditions before making attributions to specific sites and 





















In this part, we present data obtained by direct measurement of the pKa values of 
the amino groups of an aminoglycoside, neomycin, in an aminoglycoside–target 
complex. This data was used to dissect neomycin–enzyme interactions and determine 
contributions of individual amino groups of the ligand to the global thermodynamic 
properties of the enzyme–aminoglycoside complex. Our results show that binding of 
aminoglycosides to the enzyme causes upshifts in the pKa values of amino groups on the 
ligand. However, the binding affinity of aminoglycosides to APH shows a complex 
dependence on pH, and increased positive charge on the aminoglycoside does not always 
increase the affinity. 
 
 
Figure 1. Structure of neomycin B. Amino groups are shown with their numbering 
indicated in parantheses. The pKa values of the amino groups in free neomycin (1) and in 




Materials and Methods 
D2O (99.9%) was from Wilmad LabGlass (Buena, NJ), and 15N-enriched (98%) 
NH4Cl was from Cambridge Isotope Laboratories (Andover, MA). 
Protein Purification. Purification of APH was described previously (2) with the 
modifications described by Özen and Serpersu (3). Purified APH was concentrated using 
Millipore (Billerica, MA) ultrafiltration membranes and stored at –80 °C. Care was taken 
to ensure that APH remained as a monomeric protein at all times, and the monomeric 
state of the enzyme was confirmed by HPLC. The reason for taking these precautions is 
that APH is known to form dimers via two intermolecular disulfide bonds (2), and as 
shown below, the aminoglycoside binding to the dimer is significantly different from its 
binding to the monomeric enzyme. We have shown that the monomeric enzyme binds the 
aminoglycosides with a 1:1 stoichiometry (3). However, as shown in Figure 2, our 
experiments with a largely dimeric enzyme (>90%) demonstrated that one of the 
monomers has a more than 3 orders of magnitude weakened affinity to aminoglycosides 
and only tight-binding aminoglycosides, such as neomycin, can populate this low-affinity 
site. Kanamycin binds half-stoichiometrically under similar conditions. A similar half-
stoichiometric binding of aminoglycosides to aminoglycoside acetyltransferase(6′)-Iy 
(AAC) was also observed with the dimeric enzyme (4). Therefore, all experiments 
described in this paper were performed with enzyme preparations that were confirmed to 
be in the monomeric state. 
Production and Purification of 15N-Enriched Neomycin B. Streptomyces fradiae 




Figure 2. Titration of dimeric APH with neomycin. The thermogram (upper panel) is 
shown with the fitted data (lower panel), which yields association constants of 1.13 ± 




were grown in ISP 4 medium supplemented with 15NH4Cl as the sole nitrogen source in a 
New Brunswick (Edison, NJ) BioFlo 110 fermentor. The cells were grown at 28 °C for 7 
days. Following centrifugation, neomycin was isolated from the supernatant by a method 
similar to those used for the isolation and purification of kanamycin A (5) and 
ribostamycin (6); the supernatant was concentrated and loaded into an IRC-50 weak 
cation exchange column. HCl (1.0 M) was used for elution, and fractions containing 
neomycin were combined. Following pH adjustment to 7.0, the sample was concentrated 
to dryness and treated with methanol/acetone precipitation steps. Desiccated powder was 
dissolved in 10% methanol and loaded into a C18 HPLC column for further purification 
using 10% methanol as the mobile phase. The product and its purity were verified by 
NMR spectroscopy (Figure A in the Appendix) and enzymatic assays. 
15N NMR Spectroscopy of Aminoglycosides. 15N-neomycin was diluted from a 
stock solution to a Shigemi tube (Allison Park, PA) in a total volume of 275 μL at a 
concentration of 0.5 mM in 90:10 (v/v) H2O/D2O. Due to the limited availability of 15N-
neomycin and the requirement of a high enzyme-to-neomycin ratio, we initially tried 
indirect detection by 15N–1H heteronuclear single-quantum correlation (HSQC) 
experiments to achieve higher sensitivity. However, the results were not satisfactory, and 
therefore, 1D direct detection 15N NMR spectroscopy was used. One-dimensional, 1H-
decoupled 15N NMR spectra were recorded as a function of pH for the free and enzyme-
bound neomycin at 60.78 MHz on a Varian Inova 600 MHz spectrometer at 25 °C. 
Although not very high, the S/N ratio was sufficient to detect even crossovers of nitrogen 
signals in these experiments (Figure 3). When present, APH was ~0.55 mM to ensure that 
more than 95% of the neomycin was bound to the enzyme except at pH > 9.0, where the  
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Figure 3. 15N NMR spectrum of 0.5 mM free 15N-neomycin at pH 4.63 (a), at pH 6.80 
(b), and at pH 6.73 in the presence of 0.55 mM APH (c). The resonance assignments 









occupancy was ~80. Acquisition parameters included a spectral width of 6000 Hz, a 45° 
pulse length of 20 μs, and a delay of 0.5 s between scans. A total of 8–16K data points of 
20000–80000 FIDs were collected. Before Fourier transformation, 10 Hz line broadening 
was applied. All 15N chemical shifts are referenced to 15NH4Cl. The 15NH4Cl (5% 
enriched) solution was 0.1 M and was prepared in 90:10 (v/v) H2O/D2O. The pKa values 
of the amino groups of neomycin were determined by fitting the data, plotted as parts per 
million vs pH, to a nonlinear regression fit using the GraphPad Prism, version 3.02, for 
Windows, GraphPad Software (San Diego, CA). 
Isothermal Titration Calorimetry (ITC) Experiments. A VP-ITC microcalorimeter 
from Microcal, Inc. (Northampton, MA) was used to conduct the calorimetry 
experiments. The experimental temperature was 24 °C. A triple-buffer system composed 
of 25 mM MES, 25 mM HEPES, and 25 mM BICINE was used in the experiments where 
the binding affinity of aminoglycosides to the enzyme was determined as a function of 
pH. A single buffer system of 50 mM ACES, PIPES, TRIS, HEPES, BICINE, or TAPS 
was used for the determination of proton uptake by enzyme–aminoglycoside complexes 
at different pH values. In all experiments, the final potassium ion concentration was fixed 
to 100 mM using KCl. Each series of ITC experiments were performed with the same 
batch of APH that was extensively dialyzed against the ITC buffer, and ligand solutions 
were prepared in the final dialysate. As indicated above, freshly added DTT was     
always   present   in   enzyme   solutions   to   prevent   dimerization.  A  50   μM   
enzyme  solution   is   titrated   with   0.5   mM   neomycin   under   different   conditions. 
Protein and ligand solutions were degassed under vacuum for 10 min before being loaded 
into the calorimeter cell and syringe. Titrations consisted of 29 injections programmed as 
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10 μL per injection and separated by 240 s. The cell stirring speed was 300 rpm. The 
binding constant (Kb) and enthalpy change (∆H) were obtained by nonlinear least-squares 
fitting of experimental data using a single-site binding model of the Origin software 
package (version 5.0). The C-value, a parameter obtained by the multiplication of the 
association constant (Kb) and the total concentration of ligand binding sites (7), was 
within the range of 1–200 in all experiments where reliable determination of the affinity 
constant is possible. (Abbreviations: MES, 2-morpholinoethanesulfonic acid; HEPES, 4-
(2-hydroxyethyl)piperazine-1-ethanesulfonic acid; BICINE, N,N-bis(2-hydroxyethyl) 
glycine; ACES, N-(2-acetamido)-2-aminoethanesulfonic acid; PIPES, 1,4-
piperazinediethanesulfonic acid; TRIS, 2-amino-2-(hydroxymethyl)-1,3-propanediol; 
TAPS, [(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]-1-propanesulfonic acid; DTT, 
dithiothreitol.) 
 
Results and Discussion 
We employed a combination of NMR and ITC to investigate the role of ionizable 
groups and proton linkage in neomycin binding to APH. ITC was used to determine the 
net contribution of ionizable groups to the global thermodynamic properties of the binary 
enzyme–aminoglycoside complex,while NMR spectroscopy was used to identify changes 
in the pKa values of amino groups on the enzyme-bound antibiotic neomycin to determine 
their individual contributions to the thermodynamics of the APH–neomycin complex. 
NMR Studies of Free and Enzyme-Bound Neomycin. Studies of aminoglycosides 
by 15N NMR have been limited to the use of free aminoglycosides because a high 
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concentration is required for detection and 15N NMR studies of target-bound 
aminoglycosides are simply not feasible. Therefore, to date, the pKa values of amino 
functions are determined only for free aminoglycosides (1, 8–11). In this work, we report 
the first determination of pKa values in a target-bound aminoglycoside antibiotic by using 
uniformly enriched 15N-neomycin, which was prepared from cultures of S. fradiae grown 
in 15N-enriched media as described in the Materials and Methods. 
To determine the effects of binding on each amino group of neomycin, we 
acquired NMR spectra as a function of pH using 15N-enriched neomycin in the absence 
and presence of APH (Figure 3). Our 15N NMR spectra matched earlier data acquired 
with isotopically normal neomycin (1), and therefore, previously made resonance 
assignments were applied to our spectra acquired with 15N-neomycin. When present, the 
enzyme concentration was above the neomycin concentration such that more than 95% of 
the neomycin was in the binary enzyme–neomycin complex except at very high pH 
(>9.1, where ~20% of the neomycin was free). The determined pKa values of the amino 
groups in free neomycin agreed with the earlier work of Botto and Coxon (1) performed 
with isotopically normal neomycin in the absence of sulfate (sulfate is present in 
commercial preparations of aminoglycosides and, if not removed, alters the pKa values of 
the amino groups significantly).  
Addition of enzyme to the neomycin solution showed that resonances of N1 and 
N3 were significantly broadened while N2′ was shifted upfield (Figure 3). Broadening of 
N1 and N3 indicates that exchange rates are at an intermediary stage with these amino 
groups in the enzyme-bound neomycin, which precluded determination of their pKa 
values. These observations are consistent with these three nitrogens being part of a 
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“recognition motif” that adopts the same conformation when bound to enzymes or RNA 
(10, 12, 13). Also, APH shows a strong preference for the aminoglycosides with –NH2 at 
the 2′-position over those with a –OH (3), which is consistent with the observed upfield 
shift of this resonance upon binding to the enzyme. 
Chemical shifts of the four nitrogen signals representing the 2′-, 2′′′-, 6′′′-, and 6′-NH2 
groups were followed with varying pH. The change in their chemical shift as a function 
of pH is shown in Figure 4. There was also a general broadening of these signals between 
pH values of ~8.7 and 9.1, and no reliable data points were obtained within this range for 
the enzyme–neomycin complex. Better defined end points of titration, however, allowed 
curve fitting to be applied to determine pKa values. Therefore, the determined pKa   
values  for   these  groups  should  be  considered   approximate.   When   there   was    an 
overlap,   the   titration   curves   were   constructed  to  conform  with  the  expected  
shifts   for   different   nitrogens  (1)   to   yield  a   smooth   sigmoidal   curve.   The   pKa   
values   of   free   and   enzyme-bound   neomycin    are   given   in   Table   1. The data 
shown in Figure 4, however, still clearly demonstrates significant shifts in the pKa values 
of the enzyme-bound neomycin; thus, the small uncertainty in the pKa values of the 
enzyme-bound neomycin does not alter the conclusions of this work. To the best of our 
knowledge, these data represent the first pKa determination of a target-bound 
aminoglycoside antibiotic. 
As shown in Figure 4, N2′ and N2′′ amino groups show the largest shifts and 
change their pKa values by about 1 pKa unit. 6′-NH2 shows approximately 0.3 unit upshift 
in its pKa, and the N6′′′ amino group experiences no change in its pKa. Examination of the 




Figure 4. 15N chemical shift titration curves for free (lower curves) and enzyme-bound 
neomycin (upper curves, which are moved by 10 ppm up for clarity). N2′ (○), N2″′ (□), 









Table 1. pKa Values of the Amino Groups in Free and Enzyme-Bound Neomycina 
 N1 N3 N2′ N6′ N2″′ N6″′ 
free neomycin 7.9 ± 0.05 5.7 ± 0.06 7.4 ± 0.04 8.1 ± 0.02 7.7 ± 0.07 8.7 ± 0.04 
APH–neomycin ND ND 8.4 ± 0.03 8.4 ± 0.02 8.6 ± 0.04 8.7 ± 0.1 







Figure 5. Crystal structure of APH–MgADP–neomycin (14). Bound neomycin (green) is 
surrounded by a large number of acidic residues (red). The immediate environment of the 
three amino groups that show an upshifted pKa are shown in expanded views. This figure 






NH2 is exposed to solvent and the nearest carboxyl group (E230) is more than 4.5 Å 
away. Thus, no change in its pKa is consistent with the orientation of enzyme-bound 
neomycin. The N2′ and N2′′′ amino groups showed the largest shifts. The N2′ amino is 
likely to form a hydrogen bond with D190; similarly, D193 is within a H-bond distance 
of N2′′′. Thus, the shifts observed are consistent with the crystal structure of the enzyme–
MgADP–neomycin complex (14). The 6′-amino group, on the other hand, is within 2.5 Å 
of the carboxyl group of the Phe 264, which is at the C-terminus. E157 is also ~4.3 Å 
away from the 6′-amino group, yet the 6′-NH2 experiences only a shift of ~0.3 pKa unit. 
This is not consistent with the crystal structure, which suggests that either the dynamic 
properties or the conformation of the binary enzyme–neomycin complex is different 
around this amino group compared to its environment in the enzyme–MgADP–neomycin 
complex.  
Of the two amino groups whose pKa values could not be determined, N1 is within 
3 Å of E262 and less than 4 Å away from E160. Similarly, N3 is within a 3 Å distance 
from E157 and ~4.2 Å from D261. It is very likely that these groups experience 
significant shifts. Also, their proximity to more than one carboxyl side chain is consistent 
with their exchange properties. These observations show that at least three amino groups 
of neomycin experience an upshift in pKa, which causes further protonation in these 
groups upon binding to the enzyme. This number does not include N1 and N3, both of 
which are expected to have a shifted pKa. On the basis of these structural considerations, 
one would think that the increased protonation of the amino groups in neomycin should, 
in principle, increase the affinity of the antibiotic to the enzyme. However, as will be 
described later, ITC experiments showed that the binding of neomycin to APH is affected 
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by additional interactions, some of which may still dominate at low pH and reduce the 
affinity of neomycin to APH despite a highly charged state of this antibiotic. 
We note that the NMR data acquired with the binary enzyme–neomycin data are 
evaluated using the structure of the quaternary enzyme–Mg2+–ADP–neomycin complex 
due to unavailability of a structure for the binary enzyme–aminoglycoside complex. The 
selection of the binary complex for these studies is, however, still justified. First, when a 
metal–nucleotide complex is added to APH or the APH–aminoglycoside complex, no or 
very small changes are observed in the 15N-1H HSQC spectra. Contrary to this, addition 
of an aminoglycoside to the enzyme or enzyme–metal–nucleotide complex alters both 
spectra significantly and yields almost identical spectra for both complexes (15). These 
observations suggest that the environment of bound neomycin is similar in the binary and 
the quaternary complexes; thus, the conclusions of this work may largely be applicable to 
both complexes. These observations are fortuitous, but the main reason for the selection 
of the binary system is more significant and involves difficulties of data interpretation. 
ITC experiments described in the following sections are interpreted with the help of 
NMR data to understand the contributions of the microscopic protonation event to the 
calorimetric parameters. This requires that the calorimetrically observed parameters 
should reflect the behavior of the complex of interest only. While the thermodynamics of 
a binary system can be described by a single equilibrium, a ternary system can be 
described by six interdependent equilibria (16, 17), and a complete description of a 
quaternary system such as APH, Mg2+, nucleotide, and aminoglycoside requires more 
than a dozen equilibria (in reality it is even more complicated than this because there two 
bound Mg2+ ions can be seen in the crystal structures (14)). Thus, at each titration point, 
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the concentrations of various species will change and all dissociations and associations 
will contribute to the observed heat of reaction. Therefore, it would be practically 
impossible to determine the effects of pH on the relevant equilibrium alone (binding of 
neomycin to the enzyme–Mg2+–nucleotide complex), since all equilibria may be affected 
differentially as the pH is varied. Thus, attribution of the effects of pH or any other 
variable to the relevant complex (enzyme–metal–ATP–aminoglycoside) can be very 
difficult. 
Calorimetric Studies. Two different calorimetric approaches were used to 
determine binding-linked protonation/deprotonation and the effect of pH on the formation 
of the binary enzyme–neomycin complex. The first method involves determination of the 
observed enthalpy change (∆Hobs) upon ligand (aminoglycoside) binding to the enzyme 
in buffers with different ionization enthalpies (∆Hion) to derive the intrinsic enthalpy 
change (∆Hint) and the net number of binding-coupled proton exchanges (∆n). In the 
presence of binding-linked protonation, the observed enthalpy (∆Hobsd) includes 
contributions from various sources according to the equation  
∆Hobsd = ∆Hint + ∆n[α∆Hion + (1 – α)∆Henz] + ∆Hbind (18) 
in which ∆Hint is the intrinsic enthalpy of binding, ∆n represents the net proton transfer, 
∆Hobsd denotes the observed binding enthalpy of complex formation in a buffer, ∆Hion 
describes the heat of ionization of the buffer, the term ∆n[α∆Hion + (1 – α)∆Henz] 
represents the heat of ionization of groups from the ionization of the buffer and the 
protein to maintain the pH, where α represents the fraction of protonation contributed by 
the buffer (18), and ∆Hbind represents the heat of binding of the buffer to the enzyme. In 
the presence of high salt (i.e., 100 mM KCl), ∆Hbind is assumed to be zero and the 
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contribution from the ionization of amino acids remains the same at a given pH. Thus, by 
performing experiments in buffers with different heats of ionization, one can easily 
determine ∆Hint and ∆n. However, note that ∆Hint still includes the heat of ionization of 
groups contributing to ∆n (i.e., ∆Hint = (∆Hint + ∆Hfunctional groups∆n) which would represent 
the true ∆Hint only when ∆n = 0). For the buffers used in this work, a net proton uptake 
by the enzyme–ligand complex yields a positive ∆n. 
Binding-Linked Protonation. Binding-linked protonation was observed in the 
formation of the binary APH–neomycin complex. Values of ∆Hint and ∆n showed a 
strong dependence on pH as shown in Table 2. An interesting observation was made that 
there appeared to be no net binding-linked protonation or a small deprotonation occurs at 
pH 6.7 (∆n ≈ 0). This is usually taken as an indication that the determined ∆Hint under 
these conditions may be used as the true ∆Hint, which is free of contributions of ∆Hion of 
the ligand and/or enzyme groups. This is somewhat surprising because one would expect 
the pKa of N3 to upshift upon binding to the enzyme due to its proximity to the carboxyl 
groups (Figure 5). This would alone contribute to the observed ∆n by ~+0.4 at this pH. In 
addition, shifts observed in the pKa values of N2′ and N2′′′ cause a contribution of an 
additional ~0.24 from these groups, making the overall expected contribution to the 
observed ∆n to be >0.6. Thus, it is likely that deprotonation of another group may 
compensate for the combined protonation of N3, N2′, and N2′′′, yielding an overall ∆n ≤ 
0. Analysis of the data in Table 2, as described below, lends further support to the 
suggestion that other protonation/deprotonation reactions also accompany the formation 





Table 2. pH-Dependent Intrinsic Enthalpy Change (∆Hint) and Net Number of 
Binding-Coupled Proton Transfers (Δn) for the Neomycin–APH Complex 







6.7 ACES 7.5 –16.8 ± 1.7  
6.7 PIPES 2.7 –16.1 ± 1.6 
–15.7 ± 
2.0 
–0.1 ± 0.0 
      
7.6 TRIS 11.4 –9.3 ± 0.9 
7.6 HEPES 5.0 –18.9 ± 1.9 
–26.5 ± 
3.4 
1.5 ± 0.3 
      
8.5 BICINE 6.5 –21.9 ± 2.2 
8.5 TAPS 9.0 –13.3 ± 1.3 
–38.0 ± 
4.9 
2.5 ± 0.4 
aTaken from Fukada and Takahashi, 1998. bDetermined at 297 K. Uncertainties reflect 










If one assumes that ∆Hint determined at pH 6.7 is the true intrinsic enthalpy, then 
one can estimate ∆Hion of groups involved in protonation, which may then yield clues to 
the nature of these groups. The heat of formation (∆Hint) of the binary APH–neomycin 
complex becomes more negative with increasing pH. When ∆Hint, determined at the 
regime where ∆n = 0, is subtracted from values obtained at regimes where ∆n ≠ 0 and the 
result divided by ∆n, the contribution due to ∆Hion of group(s) involved in binding-linked 
protonation (groups with a shifted pKa) may be revealed. Such a calculation yields ∆Hion 
of –7.2 and –8.9 kcal/mol for the formation of the APH–neomycin complex at pH 7.6 and 
8.5, respectively. These values are somewhat lower than ∆Hion of the amino groups, 
which is about 9–10 kcal/mol (19). Assuming that the contribution of other factors such 
as cooperativity of hydrogen bonds to ∆Hint remains unaltered, these data suggest that 
several functional groups may be undergoing protonation/deprotonation reactions. 
Therefore, the observed ∆Hion represents an “average” value and precludes identification 
of the types of functional groups with altered pKa values. These data also show that the 
value observed for ∆Hion at higher pH contains more contributions from the amino groups 
since its value is closer to ∆Hion of the amino groups (19). This appears to be a trend in 
aminoglycoside–enzyme interactions. Even a larger increase in ∆Hion (from –6.4 to –10.8 
kcal/mol) was observed with increasing pH in the aminoglycoside 
nucleotidyltransferase(2′′)-Ia–neomycin complex (Wright and Serpersu, unpublished 
data), which suggests that, at high pH, protonation of the amino groups is likely to be the 
major contributor to ∆Hion in that complex as well.  
We also attempted to dissect contributions of individual amino groups of 
neomycin to the observed thermodynamic parameters. A simple calculation shows that 
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the protonation of the N2′, N2′′′, and N6′ amino functions should contribute to the 
observed ∆n by about 0.97 and 1.0 at pH 7.6 and 8.5, respectively. If the observed ∆n 
were solely due to the protonation of neomycin, then this would leave N3 and N1 as the 
only amino groups to make up the rest of the observed ∆n values. However, no 
combination of pKa values can be assigned to these groups that would add up to ∆n to 
match the observed values at both pH values. This, again, strongly suggests that 
protonation/deprotonation of other groups must contribute to the observed 
thermodynamic parameters. The active site of APH has only Asp, Glu, and Arg side 
chains as functional groups (Figure 5), none of which are normally expected to be 
involved in protonation/deprotonation in the pH regime studied. The likely functional 
group to contribute in this pH regime may be the imidazole side chain. However, the 
nearest histidine residue to any part of neomycin is ~9 Å away and is shielded from 
neomycin by other residues. Thus, these observations also suggest propagation of effects 
to remote sites upon binding of aminoglycoside to the enzyme. Such remote effects have 
been detected with other proteins (20). 
The combined contribution of N2′, N2′′′, and N6′ would be ~10 kcal/mol at pH 
7.6. Since they also account for a contribution of ~1 to ∆n, this would leave only 0.8 
kcal/mol for an additional ∆n of ~0.5, which is too small for any heat of ionization 
reaction except for carboxyl groups. This would imply that either there is no change in 
the pKa values of N1 and N3, which is very unlikely, or compensatory ionization by other 
groups contributes to the observed enthalpy. Furthermore, the same calculation for the 
data obtained at pH 8.5 yields ~12.3 kcal/mol for the additional ∆n of ~1.5, leaving ~8.2 
kcal/mol, a value much closer to the heat of ionization of the amino groups. In this case, 
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it is possible that, at pH 8.5, almost all of the heat of ionization can be attributed to the 
protonation of five amino groups in neomycin. Thus, experiments performed at two 
different pH values suggest that all protonation may occur on the ligand at high pH; 
however, at pH 7.6, other functional groups also undergo protonation/deprotonation 
reactions. 
Enzyme–Aminoglycoside Association as a Function of pH. The second 
calorimetric method involves determination of Kb for the formation of binary enzyme–
aminoglycoside complexes as a function of pH. The effect of the pH on Kb for the 
formation of the APH–neomycin complex was investigated by ITC. A pH range of 6.8–
9.1 was used in a triple-buffer system. 
The dramatic effect of the pH on Kb is shown in Figure 6 in representative ITC 
titrations. The affinity of neomycin to the enzyme was reduced at high pH. However, Kb 
does not necessarily correlate with the fractional charge on the aminoglycosides. As 
shown in Figure 7, the affinity (Kb) of neomycin to the enzyme was increased first with 
increasing pH up to pH 8.1,showed a plateau between pH 8.1 and 8.4, and then decreased 
sharply above pH 8.4. The difference between the highest and lowest Kb is more than 60-
fold in the APH–neomycin complex. The increase in affinity appears to correlate with ∆n 
and inversely correlate with the total fraction of –NH3+ ions in neomycin in the pH range 
of 6.8–8.4. The sum (∆n + [–NH3+]), however, remains essentially unchanged between 
pH 6.8 and pH 8.4, and yet Kb increases by a factor of ~6.5-fold within the same pH 
range. An increase in affinity with increasing pH suggests that deprotonation of a group 
or more is contributing favorably to the binding of neomycin to APH. This deprotonation 
is most likely to be from a functional group(s) in the enzyme. 
 
 68
Figure 6. Titration isotherms of neomycin to APH at pH 8.1 (■) and pH 9.1 (□). Raw data 
(thermal power) are given in the two upper panels. The bottom panels show the heat of 
injection, which is obtained by integration of the thermal power, plotted against the molar 
ratio of ligand to enzyme. Nonlinear curve fitting of the binding data is shown with a 
solid line. The observed binding constants (Kb) obtained from the fits of these and other 
pH experiments are given in Table 2. 
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The increase in Kb of the APH–neomycin complex as the pH is raised from 6.8 to 
8.4 is not easy to explain. Using the determined pKa values of four of the six amino 
groups in enzyme-bound neomycin, one can now determine the protonation state of the 
N2′, N2′′′, N6′, and N6′′ amino groups. At pH 6.8, these groups are >95% protonated. 
Their protonation is reduced to ~70% at pH 8.1. Thus, the net positive charge on 
neomycin experiences a decrease in this pH range, yet it has an increased affinity to the 
enzyme. It is not clear how the decrease in charge would increase the affinity of 
neomycin to APH, because almost all amino groups of enzyme-bound neomycin are near 
carboxyl functions in the active site. The N1 amino and the 2′-amino are the only groups 
that are near a positively charged enzyme functional group (R226). Early kinetic studies 
showed that an amino group at N1 and an amino or hydroxyl at the 2′ position is needed 
for a lower Km (21). Binding studies showed that aminoglycosides with an amino 
function at the 2′ position bind to APH and other aminoglycoside-modifying enzymes 
tighter than those with a hydroxy at this position and show significantly different 
thermodynamic properties (3, 22). There are no enzyme functional groups that are good 
candidates in the active site of APH to undergo protonation/deprotonation in this pH 
range. Also, the only basic side chain belongs to R226, which, normally, has a too high 
pKa to be affected in the pH range studied for binding. This leaves us with an option that 
either deprotonation of an enzyme side chain remote from the active site is increasing Kb 
via conformational changes in the enzyme, or as shown in Figure 5, the N2′ amino group 
of neomycin, despite its higher shifted pKa, may still contribute favorably upon 
deprotonation because it is the closest amino group to R226 (~4.2 Å away). However, it 
is also near two carboxyl functions, D190 and D261. Thus, the upshift in its pKa and its 
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contribution to Kb may be determined by the interplay of two opposing effects; while the 
positively charged N2′ amino interacts favorably with carboxyls, its interaction with 
R226, on the other hand, may oppose this. In this pH range, the charge on the N2′ amino 
group is reduced by 30% at pH 8.1 starting from a fully charged (>98%) state at pH 6.8. 
Thus, as the pH is raised, the unfavorable interaction between this group and R226 will 
be reduced. Another amino group that may also contribute to this is the N1 amino group, 
which is ~4.4 Å away from R226. This is, however, less likely because the pKa of N1 is 
already 7.9 in free neomycin and it is likely to be upshifted significantly upon binding 
because it is near two carboxyl groups. If this is the case, then its bound pKa may simply 
be too high to cause a significant deprotonation of N1 in the pH range of 6.8–8.1. In light 
of this, the observed effect of the pH on Kb may still reflect, in part, deprotonation of the 
2′-amino group in neomycin. 
 
Conclusions 
In this work, we determined the pKa values of amino groups for an 
aminoglycoside bound to one of its target molecules, an enzyme causing resistance to 
these antibiotics. The data permitted us to determine contributions of selected amino 
groups of the ligand to the global thermodynamic properties of the enzyme–ligand 
complex. Studies described in this paper show that binding of aminoglycoside antibiotics 
to APH involves a complex pattern of protonation and deprotonation of substrate amino 
groups and functional groups of the enzyme. Contributions from different groups at 
different pH values further complicate data analysis. These findings highlight problems 
associated with attribution of thermodynamic parameters to specific sites even in a simple 
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binary enzyme–ligand complex and underline the importance of the determination of 
thermodynamic parameters of a system under different conditions before attributing the 
observed changes in global thermodynamic parameters to specific residues/sites. These 
studies also showed that, along with structural studies, studies to determine dynamic and 
thermodynamic properties of enzyme–aminoglycoside complexes are necessary to 
understand the factors contributing to the formation of enzyme–aminoglycoside 
complexes. 
Overall, results described in this paper showed that the thermodynamics of the 
binary enzyme–aminoglycoside complexes are strongly dependent on environmental 
factors such as the pH and its effect on the ionizable groups of aminoglycosides. 
Formation of the binary aminoglycoside–APH complex is coupled to a net protonation of 
several amino groups on the ligand. However, global parameters such as ∆n, determined 
by thermodynamic studies, can sometimes be misleading. In our case, a net protonation 
was indicated by the positive sign of ∆n upon binding of neomycin to APH, but other 
studies clearly showed that binding was also accompanied by deprotonation of other 
groups, which was masked in the global parameter ∆n. In conclusion, a combination of 
NMR and calorimetric studies permitted dissection of the thermodynamic properties of 
an enzyme–aminoglycoside complex, and the contributions of individual sites on the 
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PART IV:  SOLVENT REORGANIZATION AND HEAT CAPACITY 









Water is a component in binding reactions with significant structural and 
energetic contributions. As the solvent of life, water plays crucial structural and 
functional roles in biomolecular interactions. Although its complex role is a poorly 
understood subject, it is well known that water is a reactant in binding reactions with 
significant energetic contributions (1-4). Solvent accessible surfaces of protein and ligand 
molecules are covered with water molecules (solvation) in their unbound states. With the 
formation of a binding complex, some of these water molecules are removed from the 
binding interface and returned to the bulk solvent (desolvation). Some water molecules 
may be trapped in protein-ligand interface and facilitate hydrogen bond networks. 
Solvent reorganization refers to these structural changes and has both enthalpic and 
entropic contributions to the energetics of complexes.  
One of the primary methods to evaluate the contribution of solvent to binding 
energetics is to determine enthalpy change (ΔH) of binding in light and heavy water (5, 
6) Enthalpy of a hydrogen bond is approximately 10% higher in D2O because deuterium 
forms stronger and more localized hydrogen bonds. Due to this difference, displacement 
of water molecules from apolar surfaces and formation of hydrogen bonds between 
displaced and bulk solvent molecules will result in an enthalpic difference which is a 
measure of  desolvation ΔH. Calorimetric studies utilizing solvent isotope effect on 
different biomolecular systems such as protein-carbohydrate, small molecule-small 
molecule, protein-peptide, and protein-nucleic acid show that ΔH of binding decreases in 
D2O. This change is compensated by entropic terms which leave ΔG typically 
unchanged. According to the conclusion of these studies, 25 to 100% of observed ΔH can 
 
 78
originate from solvent reorganization (6, 7).   
Heat Capacity Change of Binding Interactions. Constant pressure heat capacity 
change (ΔCp) is a thermodynamic parameter closely related to solvent reorganization (4). 
In the context of biomolecular interactions, constant pressure heat capacity change  is the 
extent to which binding enthalpy and entropy change with temperature under constant 
pressure. Analysis of ΔCp can provide insights into the molecular forces driving binding 
interactions (8-12). Since titration calorimetry is the only technique that allows direct 
determination of heat of reaction, we employed it to determine the change in the binding 
enthalpies of APH complexes with kanamycin A and neomycin B as a function of 
temperature. ΔCp for aminoglycoside-APH complexes were calculated using standard 
equation;  
 
 Over the short temperature range we studied, ΔCp didn’t show significant 
temperature dependence and therefore partial derivative terms in ΔCp equation were 
approximated to  ΔΔH / ΔT which is equal to the slope of the best-fit lines in ΔH vs 
temperature plots.  
Results reported in this section indicate a significant role played by solvent in 
aminoglycoside-APH binding. Interestingly, solvent organization seems to be different in 
the complexes of different classes of aminoglycosides. We report an unusually large 
negative heat capacity change for APH-aminoglycoside complexes. A break in ΔCp as 
well as in the temperature-dependent chemical shift patterns of four enzyme residues are 
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also observed in the APH–kanamycin complex. These residues may represent solvent 
reorganization sites on the enzyme that are away from the ligand binding site. 
 
Materials and Methods 
The aminoglycoside phosphotransferase(3')-IIIa (APH) was purified as described 
in Part II. DTT was purchased from Inalco Spa (Milano,Italy). D2O and 15N-enriched 
salts were purchased from Cambridge Isotope Laboratories (Andover, MA). 
Isothermal Titration Calorimetry (ITC). Calorimetry experiments were conducted 
using a VP-ITC microcalorimeter from Microcal, Inc. (Northampton, MA). 
Concentration of APH in calorimetry sample cell was 20 μM. Aminoglycoside 
concentration in syringe was in the 0.4 to 0.5 mM range. A buffer system composed of 50 
mM HEPES, pH 7.2, and 10 mM DTT (freshly added to the enzyme solution and 
incubated 1 hr at 24ºC before titration) was used in all experiments. Sodium ion 
concentration was adjusted to 100 mM using NaCl. H2O/D2O experiments were also 
carried out at 24ºC. Uncorrected pH-meter readings were used. In a few control 
experiments pD was adjusted according to pD = pH + 0.4 and no significant difference in 
thermodynamic parameters is observed. pH of samples used in measurement of the 
change in heat capacity experiments were also adjusted at each temperature. Samples 
were degassed under vacuum for 10 min before loading to cell and syringe of the 
calorimeter. Each titration experiment was set for 29 injections of 10 μL ligand solution 
into the sample cell with 240 sec separation. Stirring speed was set to 300 rpm. Origin 
software package (v0.5) was used for non-linear least squares fitting of binding data to a 
single site binding model.  
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Accessible Surface Area Calculations. Solvent accessible surface areas were 
calculated using NACCESS  software (13). Water probe size was defined as 1.4 A. Since 
binary APH-aminoglycoside crystal structures were not available, we used APH-ADP 
binary complex (14) and APH-MgADP-Kan or APH-MgADP-Neo crystal structures (15) 
to approximate the accessible surface area changes upon aminoglycoside binding. ΔASA 
associated heat capacity changes were calculated using parametrization developed by 
Murphy and Freire (16).  
NMR Spectroscopy. NMR spectra were acquired on a 600 MHz Varian INOVA 
spectrometer equipped with a triple-resonance probe using uniformly 15N-enriched APH. 
NMR samples contained 250 μM 15N-enriched APH in 50 mM HEPES buffer, pH 7.5, 
with 350 μM Kanamycin A or 300 μM Neomycin B to ensure at least a 95% saturation of 
the binding sites. DTT was also present at 10 mM concentration to prevent dimerization 
of the enzyme. Sensitivity-enhanced 1H–15N HSQC spectra (17) with the TROSY option 
(18) were acquired in the phase-sensitive mode using the States-Haberkorn method for 
quadrature detection in the indirect dimension (19). Datasets were obtained with a 
spectral width of 8012 Hz in the 1H dimension and 2500 Hz in the 15N dimension and 32-
64 scans of 2048 real time points for each of 80 t1 increments were recorded. The data 
were processed using the Felix processing software package (Accelerys, San Diego, CA) 
and displayed using either NMRview5 or Sparky (T. D. Goddard and D. G. Kneller, 
SPARKY 3, University of California, San Francisco) software. The 15N dimension was 
zero-filled to 256 pts, with the sensitivity enhancement option selected on the left half of 





Calorimetry Experiments with Solvent Isotopic Substitution. To study the effects 
of solvent on the formation of aminoglycoside-APH complexes, we determined binding 
parameters in H2O and D2O using ITC. Results are reported in Table 1. Difference of 
enthalpy change (ΔΔH) for complexes in H20 and D2O is plotted in Figure 1.  
As typically observed in carbohydrate-protein interactions (20, 21) , kanamycin 
group of aminoglycosides (kanamycin A, kanamycin B and tobramycin) showed more 
negative ΔH values in H2O whereas neomycin class aminoglycosides (neomycin B, 
paromomycin I and ribostamycin) yielded more negative ΔH values in D2O.  
Heat Capacity Change of Aminoglycoside-APH Complexes. ΔH of kanamycin A 
and neomycin B binding to APH was investigated as a function of temperature to 
determine heat capacity change (ΔCp) of  respective aminoglycoside-enzyme complexes. 
Results are summarized in Table 2.  
Change in binding enthalpies of both aminoglycosides show strong temperature 
dependence, yielding large negative ΔCp values which were calculated using linear 
regression of ΔH vs temperature plots (Figure 2).  
Neomycin-APH complex shows a linear change in ΔH as the temperature changes 
in the range of 18 to 35ºC with a ΔCp of -1.6 kcal/mol·deg. On the other hand, 
kanamycin binding shows a biphasic behavior with a break at 30ºC. In the range of 18 to 
30ºC, ΔCp value for kanamycin-APH complex is -0.7 kcal/mol·deg, which increases 5- 
fold and becomes -3.8 kcal/mol·deg in 30 to 37ºC range. As shown in enthalpy-entropy 
compensation (EEC) plots (Figure 3), changing ΔH values with temperature are 




Table 1. Solvent Isotope Effect on Aminoglycoside-APH Binding Parameters 
(kcal/mol). 
 ΔG ΔH ΔΔH 
 H2O D2O H2O D2O  
Kanamycin A -7.3 -7.1 -23.9 -21.6 -2.3 
Kanamycin B -6.9 -7.0 -18.9 -16.1 -2.8 
Tobramycin -6.8 -6.9 -16.7 -13.4 -3.3 
Neomycin B -8.2 -7.5 -17.0 -23.4   6.4 
Paromomycin  -9.1 -7.7 -15.3 -18.0   2.7 































Table 2. Thermodynamic data for the complexes of APH with aminoglycosides 















18 -13.7 6.2 -7.5 -14.9 6.6 -8.3 
21 -14.0 6.4 -7.6 -16.7 8.2 -8.5 
24 -18.7 10.8 -7.9 -19.9 11.3 -8.6 
27 -19.3 11.3 -8.0 -25.2 16.5 -8.7 
30 -21.5 13.3 -8.2 -31.0 22.0 -9.0 
32 -26.5 18.2 -8.3 - - - 
33 - - - -37.3 27.2 -10.1 
34 -31.0 22.7 -8.3 - - - 
35 - - - -41.0 30.4 -10.6 
35.5 -37.7 29.4 -8.3 - - - 
























Figure 2. Change in ΔH as a function of temperature for the complexes of APH with 































Figure 3. Enthalpy-Entropy Compensation (EEC) plot for kanamycin A (black) and 




1.09 and 1.02 for neomycin and kanamycin complexes respectively (R2= 0.99 in both 
cases).  
Calculation of Accessible Surface Area Change (ΔASA). According to our 
calculations, formation of kanamycin-APH complex results in burial of 724 Å2  apolar 
and 1110 Å2 polar surface area. ΔASA values of 806 Å2 and 1030 Å2 were determined 
for neomycin-APH complex for apolar and polar surfaces respectively. Figure 4 shows 
ΔASA of amino acids in complexes of APH with kanamycin and neomycin. Significant 
changes in solvent accessibility were observed  in several regions of the enzyme but 
overall changes seem to be similar in both complexes.  
NMR Studies of APH-Aminoglycoside Complexes. Thermodynamic studies yield 
parameters representing global properties of enzyme–aminoglycoside complexes. In order to 
understand site-specific implications of these parameters, we used NMR spectroscopy. 15N-
1H HSQC (will be referred as HSQC henceforth) spectrum of APH changes dramatically 
upon binding of aminoglycosides (22). HSQC spectrum of neomycin-APH complex (Figure 
5A) is shown together with overlaid spectrum of the apoenzyme (Figure 5B) acquired under 
identical conditions with matched samples. While the apoenzyme spectrum is indicative of a 
structurally flexible molecule and shows significant resonance overlap, the spectrum of the 
complex show well-resolved and highly dispersed resonances even for this ~31 kDa protein 
(264 amino acids). This suggests that APH is floppy in solution and it may even be 
intrinsically unstructured. Addition of aminoglycosides promotes formation of a well-defined 
structure. This is also consistent with crystallographic studies of the apo-and-complexed 
forms of the enzyme where apoenzyme structure is solved with lower resolution and showed 




































HSQC spectrum of APH with bound kanamycin and neomycin were acquired to 
determine effect of temperature on the backbone amide resonances of APH between 21ºC 
and 37ºC. A large number of amides showed temperature-dependent changes in their 
chemical shifts and more than 40 amides showed different temperature dependence 
between the two complexes. Figure 6 shows plots of chemical shift versus temperature for    
selected    residues    in    kanamycin-APH    and    in    neomycin-APH    complex.  
As illustrated in this figure, some amide protons did not change their chemical shifts as a 
function of temperature, while some changed in only one of the complexes, and others 
showed opposite trends. Most notably, ppm versus temperature plots of four backbone 
amide protons displayed a break at about 30ºC in the APH–kanamycin complex but not in 
the neomycin-APH complex. These amides belong to residues Leu 88, Ser 91, Cys 98, and 
Leu143 (resonance assignment of APH–aminoglycoside complexes is a work in progress). 
Expanded region of overlaid HSQC spectra showing Leu 143 peak as a function of 
temperature in neomycin-APH and in kanamycin-APH complexes is shown in Figure 7. 
Spectra shown in this figure demonstrates that while the proton chemical shift of Leu 143 is 
different for kanamycin vs. neomycin complexes at 21ºC, they merge at 31ºC and continue 
shifting at similar rates after that indicating a break for kanamycin-APH complex at ~30ºC. 
 
Discussion 
Solvent Isotopic Effects on Aminoglycoside-APH Complexes. Opposite signs of 
calculated ΔΔH values of kanamycin and neomycin class complexes (Figure 1) strongly 
suggests a difference in solvent reorganization during the formation of respective 




















Figure 6. Temperature-dependent changes in the proton chemical shifts of several amino 



















Figure 7. Expanded region of 15N-1H HSQC spectra showing Leu 143 peak as a function 
of temperature in kanamycin-APH (red, right-to-left 21ºC, 31ºC, and 38ºC respectively) 










Critical assumptions of isotopic solvent effect studies must be reminded before we 
start the discussion of ΔΔH results. These are 1) Complete deuteration of ligand and 
protein in D2O experiments, 2) Identical ΔH values associated with proton linkage. Our 
previous work on APH showed  that  aminoglycoside-APH binding is linked to 
protonation/deprotonation of ligand and enzyme ionizable groups (24). These functional 
groups may experience pKa changes in heavy water which in turn may affect the degree 
of proton linkage and associated ΔHion (ionization enthalpy change) in complex 
formation. Although prediction of such pKa changes in light versus heavy water is not 
possible, it was shown that changes in protein pKa values are almost exactly compensated 
by the difference between hydrogen and deuterium activities (25).  3) Structure of ligand, 
protein and protein-ligand complexes are assumed to be same in H2O and D2O. Therefore 
protein-ligand interactions which include number of hydrogen bonds are considered 
identical in both solvents.  
If these assumptions are met, differential hydration properties of apolar and/or 
polar groups of  ligand and protein are the most likely explanation for the observed ΔH 
differences in light and heavy water. In the case of kanamycin-APH complex, ΔH is less 
negative in D2O, which indicates that heavy water either stabilizes the unbound states or 
destabilizes the complex. The opposite should be true for neomycin-APH binding. 
There are two main structural differences between kanamycin and neomycin class 
antibiotics (Part I, Figure 1). The first one is the substitution positions of 
deoxystreptamine ring.  Kanamycin class is 4,6-, neomycin class is 4,5-disubstituted. 
Moreover, ring C is a pentose in neomycins and hexose in kanamycins. Other than these 
structural differences, relative positions of ring A and C in bound conformations of these 
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aminoglycosides are very different (26). Ring C is closer to ring A in neomycin, allowing 
formation of intra-molecular hydrogen bonds. These rings are not close in the bound 
conformation of  kanamycin. Difference in the solvent reorganization of kanamycin and 
neomycin complexes can be explained on the basis of these structural and conformational 
differences. APH can modify more than ten different aminoglycosides (15) and such a 
flexibility in the organization of water in the binding site may be playing a critical role in 
its substrate promiscuity.  
Aminoglycoside-APH Complexes Show Unusually High Heat Capacity Changes. 
Heat capacity change (ΔCp) is a thermodynamic parameter closely associated with 
solvent interactions (27-29). ΔCp values reported for various biomolecular interactions 
are typically negative values, in the range of -0.1 to -0.6 kcal/mol·deg  (30-35). For 
carbohydrate-protein interactions, these numbers are usually less than -0.2 kcal/mol·deg 
(36). In comparison, ΔCp values determined for kanamycin-APH (-0.7 and -3.8 
kcal/mol·deg) and Neomycin-APH (-1.6 kcal/mol·deg) complexes are unusually high. 
Which molecular interaction(s) contribute to ΔCp and why aminoglycoside-APH 
complexes show such a remarkable change in the heat capacity? Dissection of ΔCp is not 
an easy task due to the various energetic contributions and temperature dependence of 
factors such as solvent effects (change in solvation enthalpies) and binding-coupled, 
temperature dependent molecular processes such as proton linkage and conformational 
changes. These factors and their relative contributions will be discussed under following 
subtopics. 
Change in the Accessible Surface Area (ΔASA). Apolar and polar contact surfaces 
(binding interface) of protein and ligand molecules solvated in water molecules in their 
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unbound states are desolvated and buried upon complex formation. Traditionally, such 
changes in the accessible surface area (ΔASA) in binding reactions have been considered 
as the dominant contributor of ΔCp. Contribution of desolvation to ΔCp is proportional to 
the buried surface area. Loss of apolar surfaces make negative, loss of polar surfaces 
make positive contributions to the ΔCp. Empirical formulas that have been parameterized 
from folding and solute transfer data are used in the calculations of ΔASA associated heat 
capacity changes (27, 37). Although there are several reported cases where 
experimentally determined ΔCp values were found to be matched by computationally 
calculated ones based on ΔASA, in various other cases consideration of only desolvation 
was not enough to explain observed ΔCp values (31, 32, 34, 38, 39).  
According to our calculations, ΔASA for the formation of kanamycin-APH 
complex is 724 Å2 (apolar) and 1110 Å2 (polar). Values for neomycin-APH binding are 
806 Å2 (apolar) and 1030 Å2 (polar). These changes yield 0.037 kcal/mol·deg and 0.095 
kcal/mol·deg ΔCp contributions for the kanamycin and neomycin complexes 
respectively. These results clearly show that ΔASA is not a significant contributor to ΔCp 
of aminoglycoside-APH complexes.  
Proton Linkage and ΔCp of Ionization. Results reported in part II show that 
binding of aminoglycosides to APH is coupled to protonation/deprotonation of ligand and 
enzyme ionizable groups. Since ΔH of ionization events (buffer, protein and ligand) also 
depend on temperature, their contribution to binding ΔCp must be considered. We 
determined the ΔCp contributions from aminoglycoside amino groups as described by 
Eftink et al. (40) which yielded values between -0.12 and -0.14 kcal/mol·deg for the 
binary neomycin-APH complex. By assuming similar increases in pKa of amino 
 
 95
functions in kanamycin, one can estimate a contribution of -0.25 to -0.27 kcal/mol·deg 
for kanamycin-APH complex. Ionization ΔCp of HEPES buffer is 0.012 kcal/mol·deg 
(41). Although these values rule out ΔCp of ionization as a dominant factor, since APH 
ionazible groups are also a part of proton-coupling, their contributions may be more 
significant than the buffer and ligand groups.  
 Conformational Changes. Binding-linked conformational changes such as 
substantial ordering of a flexible region can have significant negative contributions to the 
binding heat capacity change (42). This is true especially in cases such as unwinding of 
DNA helix where ΔASA fails to explain the observed ΔCp (30, 31). HSQC spectrum of 
APH indicates highly flexible apo structure becomes a well defined one upon 
aminoglycoside binding. Significant part of the observed ΔCp may be due to such 
conformational changes in APH structure. Moreover, our earlier studies with several 
aminoglycosides showed that at least two conformations of APH-bound aminoglycosides 
are consistent with the observed NOE distance constraints (43-46). These conformations 
can interconvert to each other at 25ºC and they are different from the conformation of the 
free aminoglycosides.  Thus, binding to enzyme causes conformational changes in ligand 
as well which should also contribute to the observed large negative values for ΔCp in both 
complexes.  
We believe that combined effect of all of the factors discussed above results in the 
highly negative ΔCp of aminoglycoside-APH binding. Although it is not possible to 
determine quantitative effect of binding-linked conformational changes, it seems to be the 




Break in the Heat Capacity Change of Kanamycin-APH Complex. Typically, ΔCp 
plots represent either linear relations between ΔH and temperature or are non-linear due 
to the temperature dependence of ΔCp. ΔH of kanamycin-APH binding drastically 
changes its temperature dependence around 30°C (Figure 2). To our knowledge, there are 
only few examples of such drastic break points in literature. One of these studies report a 
very similar ΔCp break at 30ºC for the binding of netropsin to AATT containing hairpin 
DNA constructs (47). By comparing ΔCp profiles and crystal structures of related 
complexes, Freyer et. al. connected this break to the entrapment of water in the binding 
interface. Energetic consequence of this solvent structural difference is explained using 
Dunitz’s work (48) on isoequilibrium temperature for hydrogen bonding. His study 
indicates an enthalpy-entropy compensation for hydrogen bonding in water at 27°C. 
Observation of a break point in ΔCp near water’s isoequilibrium temperature strongly 
suggests a link between these two events.  
If the break point in kanamycin-APH plot is also a result of trapped water in 
binding interface and isoequilibrium temperature of water, this provides additional 
evidence for the difference of solvent structure in complexes of APH with kanamycin and 
neomycin. Although ΔASA plots (Figure 4) didn’t point to any significant difference in 
solvent accessibility of residues in aminoglycoside-APH complexes and cannot explain 
the observed break, NMR studies showed that similar breaks also occurred in the 
chemical shift changes of several backbone amides as a function of temperature. These 
residues are in hydrophobic patches distant from active site (Figure 8).  
Change of Proton Chemical Shifts as a Function of Temperature. NMR studies of 

















Figure 8.  Structure of APH–MgADP–kanamycin complex (15). Leu 88, Ser 91, Cys 98, 
and Leu 143 are shown as cpk model while all leucines are shown in pink. Kanamycin is 




that may give rise to some of the observed effects in the global thermodynamic 
properties of these complexes. HSQC experiments yielded unexpected results and 
showed that >40 backbone amide protons displayed a difference between kanamycin-
APH and neomycin-APH complexes in their chemical shifts as a function of temperature. 
Most importantly, four backbone amides paralleled the difference observed in the ΔCp 
values of kanamycin-APH and neomycin-APH complexes. Change in the proton 
chemical shifts of Leu 88, Ser 91, Cys 98, and Leu 143 showed a break at ~30ºC in the 
kanamycin-APH complex only. This is likely to represent the effect of altered water 
structure near these residues, which may have affected hydrogen bonds that these protons 
are involved in. Even the apparently most buried amino acids, Leu 143 and Cys 98, are 
flanked by hydrophilic and more exposed amino acids. This would allow formation of 
hydrogen-bonded water structures around these hydrophobic residues, which are shown 
in Figure 9. Either a conformational change in the enzyme or even a rearrangement of 
several side chains above the break point may be sufficient to alter the solvent structure 
in these regions and affect local hydrogen bond networks. Thus, HSQC experiments may 
have highlighted specific solvent reorganization sites of APH. 
An interesting fact is that most backbone amides that show the break at 30ºC are 
hydrophobic residues and are away from the substrate binding site. Furthermore, they are 
all distributed the three main hydrophobic patches of the protein, which is probably not 
coincidental. These results also indicate that reorganization of solvent is not limited to the 















Figure 9.   Environment of cys 98 and Leu 143. Left panel: Cys 98 (yellow) and its amide 
nitrogen (blue) are shown with residues Ser 99, Glu 100, Glu 101, and Tyr 102 (red 
sticks). Right panel: Leu 143 (yellow with blue nitrogen) is shown with surrounding 












Calorimetric and NMR data presented in this work indicates a difference in 
solvent reorganization of APH complexes with kanamycin and neomycin class 
aminoglycosides. Structural and conformational difference between the two drug groups 
seem to be the reason for different water interactions in respective complexes.  
We also observed unusually high heat capacity changes associated with the 
formation of aminoglycoside-APH complexes. Energetic contributions to binding ΔCp 
from ΔASA and ionization ΔCp are not significant. We believe that temperature 
dependence of enthalpy change associated with conformational changes of highly flexible 
APH and/or aminoglycoside structures may be the dominant ΔCp factor.  
Difference in solvent reorganization between the complexes of kanamycins and 
neomycins were also visible in their change of heat capacity. While both showed heat 
capacities with large negative values, APH–kanamycin complex revealed a break at 30ºC, 
above which ΔCp increased 5-fold.  
NMR experiments supported our calorimetric results indicating differences 
between kanamycin and neomycin complexes. Data showed that, parallel to the break 
observed in ΔCp determinations, there was a break in the temperature-dependent change 
in the chemical shifts of four backbone amide protons in the kanamycin-APH complex. 
No such break was visible in any amide protons (or nitrogens) in the neomycin-APH 
complex. We believe, these experiments highlighted specific solvent rearrangement sites 
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In this study, we characterized the global thermodynamic properties of 
aminoglycoside- APH complexes and dissected some of the determined parameters to 
gain insight into the structural basis of binding energy. Some of the critical findings and 
important points that need to be stressed are: 
• Calorimetry-derived thermodynamic data reflect global features of the system 
under study, which includes solvent, protein and ligand molecules in our case. 
Extreme care must be used in data interpretation and global nature of the observed 
heat signal and calculated binding parameters, which are a complex combination 
of several factors sometimes masking each other, must be always kept in mind.   
• Aminoglycoside-APH interactions are not dominated by a single type of 
intermolecular force. Combination of all interatomic forces (hydrogen bonding, 
Van der Waals forces and ionic interactions) contributes to the binding. Polar and 
apolar groups of the enzyme and its aminoglycoside substrates as well as the 
solvent have significant energetic contributions to the complex formation.   
• Formation of aminoglycoside–APH complexes are enthalpically-driven and 
entropically disfavored. Binding is linked to proton transfer which is a 
consequence of pKa changes of not only aminoglycoside but also enzyme 
ionizable groups, possibly remote from the active site.  
• Comparative analysis of binding parameters of structurally related 
aminoglycosides indicate that both 2′- and 6′- positions make enzyme contacts. 
There is no correlation between thermodynamic parameters and size, substitution 
type or kinetic parameters.   
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• There are differences in the solvent reorganization of APH complexes with 
kanamycin and neomycin class antibiotics.  
• Complex formation is associated with unusually high heat capacity change (ΔCp) 
which cannot be explained by accessible surface area change. Drastic 
conformational changes in the enzyme and substrate structures are believed to 
make significant energetic contributions to the observed ΔCp term.  
• Kanamycin-APH complex shows a break in ΔCp around 30°C. NMR experiments 
indicate a similar break in proton chemical shifts of four backbone amides which 
may indicate to specific solvent rearrangement sites.    
 
As future work, priority is on the assignment of APH residues which is an 
ongoing NMR project in our laboratory to be completed soon. Results of this work will 
allow us to follow changes in protein structure, as complexes of the enzyme are formed 
or in response to changing physical parameters, on residue basis. 
Osmotic stress experiments to complement isotopic solvent effect studies can also 
provide additional hints on the solvent reorganization in aminoglycoside-APH binding. 
Our initial results indicated specific enzyme interactions with the selected osmotic stress 
agents but we are planning to repeat these calorimetric experiments with other sets of 















Figure A. 1H NMR spectrum of cell culture medium after harvest (top), purified 15N 
neomycin (middle), and commercial neomycin (bottom). Note that chemical shifts of 
aminoglycosides are pH dependent and differences between the commercial and purified 
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